1.1 	A bill for an act
1.2 	relating to state government; modifying cannabis provisions; appropriating money;
1.3 	amending Minnesota Statutes 2022, sections 18K.03, by adding a subdivision; 
1.4 	152.22, subdivisions 11, 14, by adding a subdivision; 152.25, subdivision 2; 152.27, 
1.5 	subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.28, subdivision 2; 152.29, 
1.6 	subdivision 3; Minnesota Statutes 2023 Supplement, sections 3.9224; 151.72, 
1.7 	subdivisions 1, 2, 4, 5a, 5b, 6, 7; 152.28, subdivision 1; 152.30; 256B.0625, 
1.8 	subdivision 13d; 290.0132, subdivision 29; 290.0134, subdivision 19; 295.81, 
1.9 	subdivisions 1, 4; 297A.67, subdivision 2; 297A.70, subdivision 2; 342.01, 
1.10 	subdivisions 3, 4, 12, 14, 16, 17, 19, 20, 48, 64, 65, 66, by adding a subdivision; 
1.11 	342.02, subdivisions 2, 3, 5, 6; 342.07, subdivision 3; 342.09, subdivisions 1, 3; 
1.12 	342.10; 342.11; 342.12; 342.13; 342.14; 342.15, subdivisions 1, 2, by adding a 
1.13 	subdivision; 342.17; 342.18, subdivision 3, by adding subdivisions; 342.19, 
1.14 	subdivisions 1, 3, 4, 5; 342.22; 342.24, subdivisions 1, 2; 342.28, subdivision 2, 
1.15 	by adding a subdivision; 342.29, subdivisions 1, 4; 342.30, subdivision 4; 342.31, 
1.16 	subdivision 4; 342.32, subdivision 4; 342.35, subdivision 1; 342.37, subdivision 
1.17 	1; 342.40, subdivision 7; 342.41, subdivisions 1, 3; 342.51; 342.515; 342.52, 
1.18 	subdivisions 1, 2, 3, 4, 5, 9, 11; 342.53; 342.54; 342.55, subdivisions 1, 2; 342.56, 
1.19 	subdivisions 1, 2; 342.57, subdivisions 1, 2, 3, 4, 5, 6, 7; 342.58; 342.60; 342.61, 
1.20 	subdivisions 4, 5; 342.63, subdivisions 2, 3, 4, 6; Laws 2023, chapter 63, article 
1.21 	1, sections 2; 51; 52; 53; 54; 55; 56; 57; 58; 59; 61; article 6, sections 10; 73; 
1.22 	proposing coding for new law in Minnesota Statutes, chapter 342; repealing 
1.23 	Minnesota Statutes 2022, sections 152.22, subdivision 3; 152.36; Minnesota Statutes 
1.24 	2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54, 55; 342.18, 
1.25 	subdivision 1; 342.27, subdivision 13; 342.29, subdivision 9; 342.47; 342.48; 
1.26 	342.49; 342.50; 342.52, subdivision 8; Laws 2023, chapter 63, article 7, sections 
1.27 	4; 6.
1.28 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.29 	Section 1. Minnesota Statutes 2023 Supplement, section 3.9224, is amended to read:
1.30 	3.9224 MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.
1.31 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
1.32 	meanings given.
2.1 	(b) "Medical cannabis law" or "medical cannabis program" means the regulatory 
2.2 	framework for cultivation, production, distribution, and sale of cannabis to qualifying 
2.3 	patients for therapeutic use in the treatment of a qualifying condition.
2.4 	(c) "Medical Cannabis flower" means cannabis flower approved for sale under the 
2.5 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.6 	under this section.
2.7 	(d) "Medical cannabis product" means a cannabis product approved for sale under the 
2.8 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.9 	under this section.
2.10 	(e) "Medical cannabis business" means a medical cannabis cultivator, processor, or 
2.11 	retailer business with a medical cannabis retail endorsement.
2.12 	(f) "Medical cannabis industry" means every item, product, person, process, action, 
2.13 	business, or other thing or activity related to medical cannabis flower or medical cannabis 
2.14 	products and subject to regulation under the law of a Minnesota Tribal government or under 
2.15 	a compact entered into under this section.
2.16 	(g) "Cannabis product" means any of the following:
2.17 	(1) cannabis concentrate;
2.18 	(2) a product infused with cannabinoids, whether artificially derived, or extracted or 
2.19 	derived from cannabis plants or cannabis flower, including but not limited to 
2.20 	tetrahydrocannabinol; or
2.21 	(3) any other product that contains cannabis concentrate.
2.22 	(h) "Minnesota Tribal governments" means the following federally recognized Indian 
2.23 	Tribes located in Minnesota:
2.24 	(1) Bois Forte Band;
2.25 	(2) Fond Du Lac Band;
2.26 	(3) Grand Portage Band;
2.27 	(4) Leech Lake Band;
2.28 	(5) Mille Lacs Band;
2.29 	(6) White Earth Band;
2.30 	(7) Red Lake Nation;
3.1 	(8) Lower Sioux Indian Community;
3.2 	(9) Prairie Island Indian Community;
3.3 	(10) Shakopee Mdewakanton Sioux Community; and
3.4 	(11) Upper Sioux Indian Community.
3.5 	(i) "Tribal medical cannabis business" means a medical cannabis business licensed by 
3.6 	a Minnesota Tribal government, including the business categories identified in paragraph 
3.7 	(e), as well as any others that may be provided under the law of a Minnesota Tribal 
3.8 	government.
3.9 	(j) "Tribally regulated land" means:
3.10 	(1) all land held in trust by the United States for the benefit of a Minnesota Tribal 
3.11 	government ("trust land");
3.12 	(2) all land held by a Minnesota Tribal government in restricted fee status; and
3.13 	(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal 
3.14 	government that is subject to the civil regulatory jurisdiction of the Tribal government. For 
3.15 	the purposes of this section, land that is subject to the civil regulatory jurisdiction of the 
3.16 	Tribal government includes:
3.17 	(i) trust land, or fee land held, including leased land, by the Tribe, entities organized 
3.18 	under Tribal law, or individual Indians; and
3.19 	(ii) land held, including leased land, by non-Indian entities or individuals who consent 
3.20 	to the civil regulation of the Tribal government or are otherwise subject to such regulation 
3.21 	under federal law.
3.22 		Subd. 2.Acknowledgment and purpose; negotiations authorized. (a) The state of 
3.23 	Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate 
3.24 	the medical cannabis industry and address other matters of cannabis regulation related to 
3.25 	the internal affairs of Minnesota Tribal governments or otherwise within their jurisdiction, 
3.26 	without regard to whether such Tribal government has entered a compact authorized by this 
3.27 	section. The purpose of this section is to provide for the negotiation of compacts to 
3.28 	proactively address jurisdictional issues related to the regulation of the medical cannabis 
3.29 	industry. The legislature finds that these agreements will facilitate and promote a cooperative 
3.30 	and mutually beneficial relationship between the state and the Tribes regarding the 
3.31 	legalization of cannabis. Such cooperative agreements will enhance public health and safety, 
4.1 	ensure a lawful and well-regulated medical cannabis market, encourage economic 
4.2 	development, and provide fiscal benefits to both Indian Tribes and the state.
4.3 	(b) The governor or the governor's designee shall negotiate in good faith, and has the 
4.4 	authority to execute and bind the state to, a compact with any Minnesota Tribal government 
4.5 	wishing to enter into such a compact regulating medical cannabis flower and medical 
4.6 	cannabis products.
4.7 		Subd. 3.Terms of compact; rights of parties. (a) A compact agreed to under this 
4.8 	section may address any issues related to the medical cannabis industry, including medical
4.9 	cannabis flower, medical cannabis products, extracts, concentrates, and artificially derived 
4.10 	cannabinoids that affect the interest of both the state and Minnesota Tribal government or 
4.11 	otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter 
4.12 	into compacts pursuant to this section in order to regulate the medical cannabis industry, 
4.13 	or engage in medical cannabis businesses or activities on Tribally regulated land or participate 
4.14 	as a licensee in the state's legal medical cannabis market.
4.15 	(b) The state shall not, as a condition for entering into a compact under this section:
4.16 	(1) require any Minnesota Tribal government to waive any right, privilege, or immunity 
4.17 	based on their status as independent sovereigns;
4.18 	(2) require that any revenue generated by a medical cannabis business licensed by a 
4.19 	Minnesota Tribal government be subject to any state cannabis gross receipt taxes or state 
4.20 	and local sales or use taxes on sales of cannabis;
4.21 	(3) require any taxes collected by Minnesota Tribal governments to be shared in any 
4.22 	manner with the state or any subdivisions thereof;
4.23 	(4) require a Minnesota Tribal government to consent to state licensing of a medical 
4.24 	cannabis business on the Tribally regulated land of the Minnesota Tribal government;
4.25 	(5) require any Minnesota Tribal government or any medical cannabis business licensed 
4.26 	by a Minnesota Tribal government pursuant to a compact agreed to under this section to 
4.27 	comply with specific state law or regulations on Tribally regulated land; or
4.28 	(6) impose, or attempt to impose, and shall not require or attempt to require any Indian 
4.29 	Tribe to impose, any taxes, fees, assessments, and other charges related to the production, 
4.30 	processing, sale, purchase, distribution, or possession of medical cannabis flower and medical 
4.31 	cannabis products on Minnesota Tribal governments, or their members, on a reservation or 
4.32 	Tribally regulated land.
5.1 	(c) Compacts agreed to under this section may allow an exemption from any otherwise 
5.2 	applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal medical cannabis 
5.3 	business, or Tribal members, of medical cannabis flower and cannabis products grown, 
5.4 	produced, or processed as provided for in said compacts; or (ii) for activities of Tribal 
5.5 	medical cannabis businesses.
5.6 		Subd. 4.Civil and criminal immunities. (a) Without limiting any immunity or exemption 
5.7 	that may apply under federal law, the following acts, when performed by a Tribal medical 
5.8 	cannabis business or an employee in the course of their employment for a Tribal medical 
5.9 	cannabis business, pursuant to a compact entered into under this section, do not constitute 
5.10 	a criminal or civil offense under state law:
5.11 	(1) the cultivation of medical cannabis flower, and the extraction, processing, or 
5.12 	manufacture of medical cannabis and artificially derived cannabinoid products, extracts, or 
5.13 	concentrates;
5.14 	(2) the possession, purchase, and receipt of medical cannabis seed, cannabis flower, and 
5.15 	medical cannabis products that are properly packaged and labeled as authorized under a 
5.16 	compact entered into pursuant to this section, and the sale, delivery, transport, or distribution 
5.17 	of such products to a licensed cannabis business; and
5.18 	(3) the delivery, distribution, and sale of medical cannabis seed, cannabis flower, and 
5.19 	medical cannabis products as authorized under a compact entered into pursuant to this 
5.20 	section and that takes place on, or originates from, the premises of a Tribal medical cannabis 
5.21 	business on Tribally regulated land, to any person eligible to participate in a medical cannabis 
5.22 	program.
5.23 	(b) The following acts, when performed by a patron of a Tribal medical cannabis business 
5.24 	do not constitute a criminal or civil offense under state law: the purchase, possession, or 
5.25 	receipt of medical cannabis seed, cannabis flower, and medical cannabis products as 
5.26 	authorized under a compact entered into pursuant to this section.
5.27 	(c) Without limiting any immunity or exemption that may apply under federal law, 
5.28 	actions by a Tribal medical cannabis business, a Tribal member, employee, or agent of a 
5.29 	Minnesota Tribal government or Tribal medical cannabis business on Tribally regulated 
5.30 	land pursuant to Tribal laws governing cannabis, or a compact entered into under this section, 
5.31 	do not constitute a criminal or civil offense under state law.
5.32 	(d) The following acts, when performed by a state-licensed medical cannabis business, 
5.33 	or an employee of such business, and which would be permitted under the terms of the 
5.34 	applicable medical cannabis business license if undertaken with another state-licensed 
6.1 	medical cannabis business, are permitted under the state license conditions when undertaken 
6.2 	with a Tribal medical cannabis business and do not constitute a criminal or civil offense 
6.3 	under state law: the possession, purchase, wholesale and retail sale, delivery, transport, 
6.4 	distribution, and receipt of medical cannabis, seed, cannabis flower, and medical cannabis 
6.5 	products that are properly packaged and labeled as authorized under a compact entered into 
6.6 	pursuant to this section.
6.7 	(e) Without limiting any immunity or exemption that may apply under federal law, the 
6.8 	following acts, when performed by a Minnesota Tribal government, a Tribal medical cannabis 
6.9 	business licensed by such Tribal government, or an employee of such Tribal government 
6.10 	or Tribal medical cannabis business, regardless of whether the Minnesota Tribal government 
6.11 	issuing such license has compacted with the state under this section, do not constitute a 
6.12 	criminal or civil offense under state law: purchase, sale, receipt, or delivery (including 
6.13 	delivery that involves transit through the state, outside a reservation), of medical cannabis 
6.14 	flower, cannabis seed, and medical cannabis products from or to another Minnesota Tribal 
6.15 	government or cannabis business licensed by such government.
6.16 	(f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility 
6.17 	may provide cannabis testing services to a Tribal medical cannabis business, and the 
6.18 	possession or transport of cannabis flower or cannabis products for such purpose by a Tribal 
6.19 	cannabis business shall not constitute a criminal or civil offense under state law.
6.20 		Subd. 5.Publication. The governor shall post any compact entered into under this section 
6.21 	on a publicly accessible website.

6.22 	EFFECTIVE DATE. This section is effective the day following final enactment.

6.23 	Sec. 2. Minnesota Statutes 2022, section 18K.03, is amended by adding a subdivision to 
6.24 	read:
6.25 		Subd. 3.Sale to cannabis and hemp businesses. (a) An industrial hemp grower licensed 
6.26 	under this chapter may sell hemp plant parts and propagules to a cannabis business or hemp 
6.27 	business licensed under chapter 342.
6.28 	(b) An industrial hemp processor licensed under this chapter may sell hemp concentrate 
6.29 	to a cannabis business or hemp business licensed under chapter 342.

7.1 	Sec. 3. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended 
7.2 	to read:
7.3 		Subdivision 1.Definitions. For the purposes of this section, the following terms have 
7.4 	the meanings given.
7.5 	(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant 
7.6 	or hemp plant parts with a chemical makeup that is changed after extraction to create a 
7.7 	different cannabinoid or other chemical compound by applying a catalyst other than heat 
7.8 	or light. Artificially derived cannabinoid includes but is not limited to any 
7.9 	tetrahydrocannabinol created from cannabidiol.
7.10 	(b) "Batch" means a specific quantity of a specific product containing cannabinoids 
7.11 	derived from hemp, including an edible cannabinoid product, that is manufactured at the 
7.12 	same time and using the same methods, equipment, and ingredients that is uniform and 
7.13 	intended to meet specifications for identity, strength, purity, and composition, and that is 
7.14 	manufactured, packaged, and labeled according to a single batch production record executed 
7.15 	and documented.
7.16 	(c) "Certified hemp" means hemp plants that have been tested and found to meet the 
7.17 	requirements of chapter 18K and the rules adopted thereunder.
7.18 	(d) "Commissioner" means the commissioner of health.
7.19 	(e) (d) "Distributor" means a person who sells, arranges a sale, or delivers a product 
7.20 	containing cannabinoids derived from hemp, including an edible cannabinoid product, that 
7.21 	the person did not manufacture to a retail establishment for sale to consumers. Distributor 
7.22 	does not include a common carrier used only to complete delivery to a retailer.
7.23 	(f) (e) "Edible cannabinoid product" means any product that is intended to be eaten or 
7.24 	consumed as a beverage by humans, contains a cannabinoid in combination with food 
7.25 	ingredients, and is not a drug.
7.26 	(g) (f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 
7.27 	3.
7.28 	(h) (g) "Label" has the meaning given in section 151.01, subdivision 18.
7.29 	(i) (h) "Labeling" means all labels and other written, printed, or graphic matter that are:
7.30 	(1) affixed to the immediate container in which a product regulated under this section 
7.31 	is sold;
8.1 	(2) provided, in any manner, with the immediate container, including but not limited to 
8.2 	outer containers, wrappers, package inserts, brochures, or pamphlets; or
8.3 	(3) provided on that portion of a manufacturer's website that is linked by a scannable 
8.4 	barcode or matrix barcode.
8.5 	(j) (i) "Matrix barcode" means a code that stores data in a two-dimensional array of 
8.6 	geometrically shaped dark and light cells capable of being read by the camera on a 
8.7 	smartphone or other mobile device.
8.8 	(k) (j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp 
8.9 	plants that do not produce intoxicating effects when consumed by any route of administration.
8.10 	(k) "Office" means the Office of Cannabis Management.
8.11 	(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and 
8.12 	pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp 
8.13 	plants, or hemp plant parts and is instead created or produced by chemical or biochemical 
8.14 	synthesis.
8.15 	(m) "Tincture" means a solution of hemp extract, derived either directly from a hemp 
8.16 	plant or from a manufactured hemp extract, dissolved in glycerin, food-grade oils, or other 
8.17 	food-grade solvents and is intended to be eaten as an edible cannabinoid product under 
8.18 	section 151.72, paragraph (f).

8.19 	Sec. 4. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended 
8.20 	to read:
8.21 		Subd. 2.Scope. (a) This section applies to the sale of any product that contains 
8.22 	cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended 
8.23 	for human or animal consumption by any route of administration.
8.24 	(b) This section does not apply to any product dispensed by a registered medical cannabis 
8.25 	manufacturer pursuant to sections 152.22 to 152.37.
8.26 	(c) The commissioner office must have no authority over food products, as defined in 
8.27 	section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from 
8.28 	hemp.

9.1 	Sec. 5. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended 
9.2 	to read:
9.3 		Subd. 4.Testing requirements. (a) A manufacturer of a product regulated under this 
9.4 	section must submit representative samples of each batch of the product to an independent, 
9.5 	accredited laboratory in order to certify that the product complies with the standards adopted 
9.6 	by the board on or before July 1, 2023, or the standards adopted by the commissioner office. 
9.7 	Testing must be consistent with generally accepted industry standards for herbal and botanical 
9.8 	substances, and, at a minimum, the testing must confirm that the product:
9.9 	(1) contains the amount or percentage of cannabinoids that is stated on the label of the 
9.10 	product;
9.11 	(2) does not contain more than trace amounts of any mold, residual solvents or other 
9.12 	catalysts, pesticides, fertilizers, or heavy metals; and
9.13 	(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.
9.14 	(b) A manufacturer of a product regulated under this section must disclose all known 
9.15 	information regarding pesticides, fertilizers, solvents, or other foreign materials applied to 
9.16 	industrial hemp or added to industrial hemp during any production or processing stages of 
9.17 	any batch from which a representative sample has been sent for testing, including any 
9.18 	catalysts used to create artificially derived cannabinoids. The disclosure must be made to 
9.19 	the laboratory performing testing or sampling and, upon request, to the commissioner office. 
9.20 	The disclosure must include all information known to the licensee manufacturer regardless 
9.21 	of whether the application or addition was made intentionally or accidentally, or by the 
9.22 	manufacturer or any other person.
9.23 	(c) Upon the request of the commissioner office, the manufacturer of the product must 
9.24 	provide the commissioner office with the results of the testing required in this section.
9.25 	(d) The commissioner office may determine that any testing laboratory that does not 
9.26 	operate formal management systems under the International Organization for Standardization 
9.27 	is not an accredited laboratory and require that a representative sample of a batch of the 
9.28 	product be retested by a testing laboratory that meets this requirement.
9.29 	(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or 
9.30 	possession of a certificate of analysis for such hemp, does not meet the testing requirements 
9.31 	of this section.

10.1 	Sec. 6. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended 
10.2 	to read:
10.3 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
10.4 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
10.5 	must meet the requirements of this subdivision.
10.6 	(b) An edible cannabinoid product must not:
10.7 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
10.8 	animal, or fruit that appeals to children;
10.9 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
10.10 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
10.11 	commercially available candy or snack food item;
10.12 	(4) be substantively similar to a meat food product; poultry food product as defined in 
10.13 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
10.14 	7;
10.15 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
10.16 	by the United States Food and Drug Administration for use in food;
10.17 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
10.18 	product-specialized packaging of any commercially available food product; or
10.19 	(7) be packaged in a container that includes a statement, artwork, or design that could 
10.20 	reasonably mislead any person to believe that the package contains anything other than an 
10.21 	edible cannabinoid product.
10.22 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
10.23 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
10.24 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
10.25 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
10.26 	that is intended to be consumed as a beverage.
10.27 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
10.28 	as a beverage, is intended for more than a single use or contains multiple servings, each 
10.29 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
10.30 	serving size that appear on the edible cannabinoid product.
10.31 	(e) A label containing at least the following information must be affixed to the packaging 
10.32 	or container of all edible cannabinoid products sold to consumers:
11.1 	(1) the serving size;
11.2 	(2) the cannabinoid profile per serving and in total;
11.3 	(3) a list of ingredients, including identification of any major food allergens declared 
11.4 	by name; and
11.5 	(4) the following statement: "Keep this product out of reach of children."
11.6 	(f) An edible cannabinoid product must not contain more than five milligrams of any 
11.7 	tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product 
11.8 	that is intended to be consumed as a beverage, may not contain more than a total of 50 
11.9 	milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that 
11.10 	is intended to be consumed as a beverage may not contain more than two servings per 
11.11 	container.
11.12 	(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 
11.13 	tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an 
11.14 	artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing 
11.15 	any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and 
11.16 	HHC, unless the commissioner office authorizes use of the artificially derived cannabinoid 
11.17 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
11.18 	synthetic cannabinoids.
11.19 	(h) Every person selling edible cannabinoid products to consumers, other than products 
11.20 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
11.21 	products are displayed behind a checkout counter where the public is not permitted or in a 
11.22 	locked case.

11.23 	Sec. 7. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended 
11.24 	to read:
11.25 		Subd. 5b.Registration; prohibitions. (a) On or before October 1, 2023, every person 
11.26 	selling edible cannabinoid products to consumers must register with the commissioner in 
11.27 	a form and manner established by the commissioner. After October 1, 2023, the sale of 
11.28 	edible cannabinoid products by a person that is not registered is prohibited.
11.29 	(a) Every person selling an edible cannabinoid product to a consumer must be registered 
11.30 	with the office. All existing registrations with the Department of Health, Office of Medical 
11.31 	Cannabis, as of June 30, 2024, will automatically transfer to the office on July 1, 2024. All 
11.32 	other persons required to register must register in a form and manner established by the 
12.1 	office. The sale of edible cannabinoid products by a person who is not registered with the 
12.2 	office is prohibited.
12.3 	(b) The registration form must contain an attestation of compliance and each registrant 
12.4 	must affirm that it is operating and will continue to operate in compliance with the 
12.5 	requirements of this section and all other applicable state and local laws and ordinances.
12.6 	(c) The commissioner shall office must not charge a fee for registration under this 
12.7 	subdivision.

12.8 	Sec. 8. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended 
12.9 	to read:
12.10 		Subd. 6.Noncompliant products; enforcement. (a) A product regulated under this 
12.11 	section, including an edible cannabinoid product, shall be considered a noncompliant product 
12.12 	if the product is offered for sale in this state or if the product is manufactured, imported, 
12.13 	distributed, or stored with the intent to be offered for sale in this state in violation of any 
12.14 	provision of this section, including but not limited to if:
12.15 	(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;
12.16 	(2) it has been produced, prepared, packed, or held under unsanitary conditions where 
12.17 	it may have been rendered injurious to health, or where it may have been contaminated with 
12.18 	filth;
12.19 	(3) its container is composed, in whole or in part, of any poisonous or deleterious 
12.20 	substance that may render the contents injurious to health;
12.21 	(4) it contains any food additives, color additives, or excipients that have been found by 
12.22 	the FDA to be unsafe for human or animal consumption;
12.23 	(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different 
12.24 	than the amount or percentage stated on the label;
12.25 	(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is 
12.26 	an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits 
12.27 	established in subdivision 5a, paragraph (f); or
12.28 	(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, 
12.29 	or heavy metals.
12.30 	(b) A product regulated under this section shall be considered a noncompliant product 
12.31 	if the product's labeling is false or misleading in any manner or in violation of the 
12.32 	requirements of this section.
13.1 	(c) The commissioner office may assume that any product regulated under this section 
13.2 	that is present in the state, other than a product lawfully possessed for personal use, has 
13.3 	been manufactured, imported, distributed, or stored with the intent to be offered for sale in 
13.4 	this state if a product of the same type and brand was sold in the state on or after July 1, 
13.5 	2023, or if the product is in the possession of a person who has sold any product in violation 
13.6 	of this section.
13.7 	(d) The commissioner office may enforce this section, including enforcement against a 
13.8 	manufacturer or distributor of a product regulated under this section, under sections 144.989 
13.9 	to 144.993 section 342.19.
13.10 	(e) The commissioner may enter into an interagency agreement with The office of 
13.11 	Cannabis Management and may enter into an interagency agreement with the commissioner 
13.12 	of agriculture to perform inspections and take other enforcement actions on behalf of the 
13.13 	commissioner office.

13.14 	Sec. 9. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended 
13.15 	to read:
13.16 		Subd. 7.Violations; criminal penalties. (a) Notwithstanding section 144.99, subdivision 
13.17 	11, A person who does any of the following regarding a product regulated under this section 
13.18 	is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 
13.19 	364 days or to payment of a fine of not more than $3,000, or both:
13.20 	(1) knowingly alters or otherwise falsifies testing results;
13.21 	(2) intentionally alters or falsifies any information required to be included on the label 
13.22 	of an edible cannabinoid product; or
13.23 	(3) intentionally makes a false material statement to the commissioner office.
13.24 	(b) Notwithstanding section 144.99, subdivision 11, A person who does any of the 
13.25 	following on the premises of a registered retailer or another business that sells retail goods 
13.26 	to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for 
13.27 	not more than 364 days or to payment of a fine of not more than $3,000, or both:
13.28 	(1) sells an edible cannabinoid product knowing that the product does not comply with 
13.29 	the limits on the amount or types of cannabinoids that a product may contain;
13.30 	(2) sells an edible cannabinoid product knowing that the product does not comply with 
13.31 	the applicable testing, packaging, or labeling requirements; or
14.1 	(3) sells an edible cannabinoid product to a person under the age of 21, except that it is 
14.2 	an affirmative defense to a charge under this clause if the defendant proves by a 
14.3 	preponderance of the evidence that the defendant reasonably and in good faith relied on 
14.4 	proof of age as described in subdivision 5c.

14.5 	Sec. 10. Minnesota Statutes 2022, section 152.22, subdivision 11, is amended to read:
14.6 		Subd. 11.Registered designated caregiver. "Registered designated caregiver" means 
14.7 	a person who:
14.8 	(1) is at least 18 years old;
14.9 	(2) does not have a conviction for a disqualifying felony offense;
14.10 	(3) (2) has been approved by the commissioner office to assist a patient who requires 
14.11 	assistance in administering medical cannabis or obtaining medical cannabis from a 
14.12 	distribution facility; and
14.13 	(4) (3) is authorized by the commissioner office to assist the patient with the use of 
14.14 	medical cannabis.

14.15 	EFFECTIVE DATE. This section is effective July 1, 2024.

14.16 	Sec. 11. Minnesota Statutes 2022, section 152.22, subdivision 14, is amended to read:
14.17 		Subd. 14.Qualifying medical condition. "Qualifying medical condition" means a 
14.18 	diagnosis of any of the following conditions:
14.19 	(1) Alzheimer's disease;
14.20 	(2) autism spectrum disorder that meets the requirements of the fifth edition of the 
14.21 	Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric 
14.22 	Association;
14.23 	(1) (3) cancer, if the underlying condition or treatment produces one or more of the 
14.24 	following:
14.25 	(i) severe or chronic pain;
14.26 	(ii) nausea or severe vomiting; or
14.27 	(iii) cachexia or severe wasting;
14.28 	(4) chronic motor or vocal tic disorder;
14.29 	(5) chronic pain;
15.1 	(2) (6) glaucoma;
15.2 	(3) (7) human immunodeficiency virus or acquired immune deficiency syndrome;
15.3 	(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
15.4 	(9) obstructive sleep apnea;
15.5 	(10) post-traumatic stress disorder;
15.6 	(4) (11) Tourette's syndrome;
15.7 	(5) (12) amyotrophic lateral sclerosis;
15.8 	(6) (13) seizures, including those characteristic of epilepsy;
15.9 	(7) (14) severe and persistent muscle spasms, including those characteristic of multiple 
15.10 	sclerosis;
15.11 	(8) (15) inflammatory bowel disease, including Crohn's disease;
15.12 	(16) irritable bowel syndrome;
15.13 	(17) obsessive-compulsive disorder;
15.14 	(18) sickle cell disease;
15.15 	(9) (19) terminal illness, with a probable life expectancy of under one year, if the illness 
15.16 	or its treatment produces one or more of the following:
15.17 	(i) severe or chronic pain;
15.18 	(ii) nausea or severe vomiting; or
15.19 	(iii) cachexia or severe wasting; or
15.20 	(10) (20) any other medical condition or its treatment approved by the commissioner
15.21 	office.

15.22 	EFFECTIVE DATE. This section is effective July 1, 2024.

15.23 	Sec. 12. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
15.24 	read:
15.25 		Subd. 19.Veteran. "Veteran" means an individual who satisfies the requirements in 
15.26 	section 197.447 and is receiving care from the United States Department of Veterans Affairs.

15.27 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.1 	Sec. 13. Minnesota Statutes 2022, section 152.25, subdivision 2, is amended to read:
16.2 		Subd. 2.Range of compounds and dosages; report. The commissioner office shall 
16.3 	review and publicly report the existing medical and scientific literature regarding the range 
16.4 	of recommended dosages for each qualifying condition and the range of chemical 
16.5 	compositions of any plant of the genus cannabis that will likely be medically beneficial for 
16.6 	each of the qualifying medical conditions. The commissioner office shall make this 
16.7 	information available to patients with qualifying medical conditions beginning December 
16.8 	1, 2014, and update the information annually every three years. The commissioner office
16.9 	may consult with the independent laboratory under contract with the manufacturer or other 
16.10 	experts in reporting the range of recommended dosages for each qualifying medical condition, 
16.11 	the range of chemical compositions that will likely be medically beneficial, and any risks 
16.12 	of noncannabis drug interactions. The commissioner office shall consult with each 
16.13 	manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list 
16.14 	of medical cannabis offered by a manufacturer shall be published on the Department of 
16.15 	Health Office of Cannabis Management website.

16.16 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.17 	Sec. 14. Minnesota Statutes 2022, section 152.27, subdivision 1, is amended to read:
16.18 		Subdivision 1.Patient registry program; establishment. (a) The commissioner office
16.19 	shall establish a patient registry program to evaluate data on patient demographics, effective 
16.20 	treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting 
16.21 	on the benefits, risks, and outcomes regarding patients with a qualifying medical condition 
16.22 	engaged in the therapeutic use of medical cannabis.
16.23 	(b) The establishment of the registry program shall not be construed or interpreted to 
16.24 	condone or promote the illicit recreational use of marijuana.

16.25 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.26 	Sec. 15. Minnesota Statutes 2022, section 152.27, subdivision 2, is amended to read:
16.27 		Subd. 2.Commissioner Office duties. (a) The commissioner office shall:
16.28 	(1) give notice of the program to health care practitioners in the state who are eligible 
16.29 	to serve as health care practitioners and explain the purposes and requirements of the 
16.30 	program;
17.1 	(2) allow each health care practitioner who meets or agrees to meet the program's 
17.2 	requirements and who requests to participate, to be included in the registry program to 
17.3 	collect data for the patient registry;
17.4 	(3) provide explanatory information and assistance to each health care practitioner in 
17.5 	understanding the nature of therapeutic use of medical cannabis within program requirements;
17.6 	(4) create and provide a certification to be used by a health care practitioner for the 
17.7 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
17.8 	condition and include in the certification an option for the practitioner to certify whether 
17.9 	the patient, in the health care practitioner's medical opinion, is developmentally or physically 
17.10 	disabled and, as a result of that disability, the patient requires assistance in administering 
17.11 	medical cannabis or obtaining medical cannabis from a distribution facility;
17.12 	(5) supervise the participation of the health care practitioner in conducting patient 
17.13 	treatment and health records reporting in a manner that ensures stringent security and 
17.14 	record-keeping requirements and that prevents the unauthorized release of private data on 
17.15 	individuals as defined by section 13.02;
17.16 	(6) develop safety criteria for patients with a qualifying medical condition as a 
17.17 	requirement of the patient's participation in the program, to prevent the patient from 
17.18 	undertaking any task under the influence of medical cannabis that would constitute negligence 
17.19 	or professional malpractice on the part of the patient; and
17.20 	(7) conduct research and studies based on data from health records submitted to the 
17.21 	registry program and submit reports on intermediate or final research results to the legislature 
17.22 	and major scientific journals. The commissioner office may contract with a third party to 
17.23 	complete the requirements of this clause. Any reports submitted must comply with section 
17.24 	152.28, subdivision 2.
17.25 	(b) The commissioner office may add a delivery method under section 152.22, subdivision 
17.26 	6, or add, remove, or modify a qualifying medical condition under section 152.22, subdivision 
17.27 	14, upon a petition from a member of the public or the task force on medical cannabis 
17.28 	therapeutic research Cannabis Advisory Council under section 342.03, or as directed by 
17.29 	law. The commissioner office shall evaluate all petitions to add a qualifying medical condition 
17.30 	or to remove or modify an existing qualifying medical condition submitted by the task force 
17.31 	on medical cannabis therapeutic research Cannabis Advisory Council under section 342.03,
17.32 	or as directed by law and may make the addition, removal, or modification if the 
17.33 	commissioner office determines the addition, removal, or modification is warranted based 
17.34 	on the best available evidence and research. If the commissioner office wishes to add a 
18.1 	delivery method under section 152.22, subdivision 6, or add or remove modify a qualifying 
18.2 	medical condition under section 152.22, subdivision 14, the commissioner office must notify 
18.3 	the chairs and ranking minority members of the legislative policy committees having 
18.4 	jurisdiction over health and public safety of the addition or removal modification and the 
18.5 	reasons for its addition or removal modification, including any written comments received 
18.6 	by the commissioner office from the public and any guidance received from the task force 
18.7 	on medical cannabis research Cannabis Advisory Council under section 342.03, by January 
18.8 	15 of the year in which the commissioner office wishes to make the change. The change 
18.9 	shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

18.10 	EFFECTIVE DATE. This section is effective July 1, 2024.

18.11 	Sec. 16. Minnesota Statutes 2022, section 152.27, subdivision 3, is amended to read:
18.12 		Subd. 3.Patient application. (a) The commissioner office shall develop a patient 
18.13 	application for enrollment into the registry program. The application shall be available to 
18.14 	the patient and given to health care practitioners in the state who are eligible to serve as 
18.15 	health care practitioners. The application must include:
18.16 	(1) the name, mailing address, and date of birth of the patient;
18.17 	(2) the name, mailing address, and telephone number of the patient's health care 
18.18 	practitioner;
18.19 	(3) the name, mailing address, and date of birth of the patient's designated caregiver, if 
18.20 	any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse 
18.21 	will be acting as a caregiver;
18.22 	(4) a copy of the certification from the patient's health care practitioner that is dated 
18.23 	within 90 days prior to submitting the application that certifies that the patient has been 
18.24 	diagnosed with a qualifying medical condition; and
18.25 	(5) all other signed affidavits and enrollment forms required by the commissioner office
18.26 	under sections 152.22 to 152.37, including, but not limited to, the disclosure form required 
18.27 	under paragraph (c) (b).
18.28 	(b) The commissioner shall require a patient to resubmit a copy of the certification from 
18.29 	the patient's health care practitioner on a yearly basis and shall require that the recertification 
18.30 	be dated within 90 days of submission.
18.31 	(c) (b) The commissioner office shall develop a disclosure form and require, as a condition 
18.32 	of enrollment, all patients to sign a copy of the disclosure. The disclosure must include:
19.1 	(1) a statement that, notwithstanding any law to the contrary, the commissioner office, 
19.2 	or an employee of any state agency, may not be held civilly or criminally liable for any 
19.3 	injury, loss of property, personal injury, or death caused by any act or omission while acting 
19.4 	within the scope of office or employment under sections 152.22 to 152.37; and
19.5 	(2) the patient's acknowledgment that enrollment in the patient registry program is 
19.6 	conditional on the patient's agreement to meet all of the requirements of sections 152.22 to 
19.7 	152.37.

19.8 	EFFECTIVE DATE. This section is effective July 1, 2024.

19.9 	Sec. 17. Minnesota Statutes 2022, section 152.27, is amended by adding a subdivision to 
19.10 	read:
19.11 		Subd. 3a.Application procedure for veterans. (a) Beginning July 1, 2024, the 
19.12 	commissioner shall establish an alternative certification procedure for veterans to confirm 
19.13 	that the veteran has been diagnosed with a qualifying medical condition.
19.14 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
19.15 	submit a copy of the patient's veteran health identification card issued by the United States 
19.16 	Department of Veterans Affairs and an application established by the commissioner to 
19.17 	certify that the patient has been diagnosed with a qualifying medical condition.

19.18 	EFFECTIVE DATE. This section is effective July 1, 2024.

19.19 	Sec. 18. Minnesota Statutes 2022, section 152.27, subdivision 4, is amended to read:
19.20 		Subd. 4.Registered designated caregiver. (a) The commissioner office shall register 
19.21 	a designated caregiver for a patient if the patient requires assistance in administering medical 
19.22 	cannabis or obtaining medical cannabis from a distribution facility and the caregiver has 
19.23 	agreed, in writing, to be the patient's designated caregiver. As a condition of registration as 
19.24 	a designated caregiver, the commissioner shall require the person to:
19.25 	(1) be at least 18 years of age;
19.26 	(2) agree to only possess the patient's medical cannabis for purposes of assisting the 
19.27 	patient; and
19.28 	(3) agree that if the application is approved, the person will not be a registered designated 
19.29 	caregiver for more than six registered patients at one time. Patients who reside in the same 
19.30 	residence shall count as one patient.
20.1 	(b) The commissioner shall conduct a criminal background check on the designated 
20.2 	caregiver prior to registration to ensure that the person does not have a conviction for a 
20.3 	disqualifying felony offense. Any cost of the background check shall be paid by the person 
20.4 	seeking registration as a designated caregiver. A designated caregiver must have the criminal 
20.5 	background check renewed every two years.
20.6 	(c) (b) Nothing in sections 152.22 to 152.37 shall be construed to prevent a person 
20.7 	registered as a designated caregiver from also being enrolled in the registry program as a 
20.8 	patient and possessing and using medical cannabis as a patient.

20.9 	EFFECTIVE DATE. This section is effective July 1, 2024.

20.10 	Sec. 19. Minnesota Statutes 2022, section 152.27, subdivision 6, is amended to read:
20.11 		Subd. 6.Patient enrollment. (a) After receipt of a patient's application, application fees,
20.12 	and signed disclosure, the commissioner office shall enroll the patient in the registry program 
20.13 	and issue the patient and patient's registered designated caregiver or parent, legal guardian, 
20.14 	or spouse, if applicable, a registry verification. The commissioner office shall approve or 
20.15 	deny a patient's application for participation in the registry program within 30 days after 
20.16 	the commissioner office receives the patient's application and application fee. The 
20.17 	commissioner may approve applications up to 60 days after the receipt of a patient's 
20.18 	application and application fees until January 1, 2016. A patient's enrollment in the registry 
20.19 	program shall only be denied if the patient:
20.20 	(1) does not have certification from a health care practitioner, or if the patient is a veteran 
20.21 	receiving care from the United States Department of Veterans Affairs, who does not have 
20.22 	the documentation required under subdivision 3a that the patient has been diagnosed with 
20.23 	a qualifying medical condition;
20.24 	(2) has not signed and returned the disclosure form required under subdivision 3, 
20.25 	paragraph (c), to the commissioner office;
20.26 	(3) does not provide the information required;
20.27 	(4) has previously been removed from the registry program for violations of section 
20.28 	152.30 or 152.33; or
20.29 	(5) provides false information.
20.30 	(b) The commissioner office shall give written notice to a patient of the reason for 
20.31 	denying enrollment in the registry program.
21.1 	(c) Denial of enrollment into the registry program is considered a final decision of the 
21.2 	commissioner office and is subject to judicial review under the Administrative Procedure 
21.3 	Act pursuant to chapter 14.
21.4 	(d) A patient's enrollment in the registry program may only be revoked upon the death 
21.5 	of the patient or if a patient violates a requirement under section 152.30 or 152.33.
21.6 	(e) The commissioner office shall develop a registry verification to provide to the patient, 
21.7 	the health care practitioner identified in the patient's application, and to the manufacturer. 
21.8 	The registry verification shall include:
21.9 	(1) the patient's name and date of birth;
21.10 	(2) the patient registry number assigned to the patient; and
21.11 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
21.12 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
21.13 	spouse will be acting as a caregiver.

21.14 	EFFECTIVE DATE. This section is effective July 1, 2024.

21.15 	Sec. 20. Minnesota Statutes 2023 Supplement, section 152.28, subdivision 1, is amended 
21.16 	to read:
21.17 		Subdivision 1.Health care practitioner duties. (a) Prior to a patient's enrollment in 
21.18 	the registry program, a health care practitioner shall:
21.19 	(1) determine, in the health care practitioner's medical judgment, whether a patient suffers 
21.20 	from a qualifying medical condition, and, if so determined, provide the patient with a 
21.21 	certification of that diagnosis;
21.22 	(2) advise patients, registered designated caregivers, and parents, legal guardians, or 
21.23 	spouses who are acting as caregivers of the existence of any nonprofit patient support groups 
21.24 	or organizations;
21.25 	(3) provide explanatory information from the commissioner to patients with qualifying 
21.26 	medical conditions, including disclosure to all patients about the experimental nature of 
21.27 	therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the 
21.28 	proposed treatment; the application and other materials from the commissioner; and provide 
21.29 	patients with the Tennessen warning as required by section 13.04, subdivision 2; and
21.30 	(4) agree to continue treatment of the patient's qualifying medical condition and report 
21.31 	medical findings to the commissioner.
22.1 	(b) Upon notification from the commissioner of the patient's enrollment in the registry 
22.2 	program, the health care practitioner shall:
22.3 	(1) participate in the patient registry reporting system under the guidance and supervision 
22.4 	of the commissioner;
22.5 	(2) report health records of the patient throughout the ongoing treatment of the patient 
22.6 	to the commissioner in a manner determined by the commissioner and in accordance with 
22.7 	subdivision 2;
22.8 	(3) determine, on a yearly basis every three years, if the patient continues to suffer from 
22.9 	a qualifying medical condition and, if so, issue the patient a new certification of that 
22.10 	diagnosis; and
22.11 	(4) otherwise comply with all requirements developed by the commissioner.
22.12 	(c) A health care practitioner may utilize telehealth, as defined in section 62A.673, 
22.13 	subdivision 2, for certifications and recertifications.
22.14 	(d) Nothing in this section requires a health care practitioner to participate in the registry 
22.15 	program.

22.16 	EFFECTIVE DATE. This section is effective July 1, 2024.

22.17 	Sec. 21. Minnesota Statutes 2022, section 152.28, subdivision 2, is amended to read:
22.18 		Subd. 2.Data. Data collected on patients by a health care practitioner and reported to 
22.19 	the patient registry, including data on patients who are veterans who receive care from the 
22.20 	United States Department of Veterans Affairs, are health records under section 144.291, 
22.21 	and are private data on individuals under section 13.02, but may be used or reported in an 
22.22 	aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research 
22.23 	conducted under section 152.25 or in the creation of summary data, as defined in section 
22.24 	13.02, subdivision 19.

22.25 	EFFECTIVE DATE. This section is effective July 1, 2024.

22.26 	Sec. 22. Minnesota Statutes 2022, section 152.29, subdivision 3, is amended to read:
22.27 		Subd. 3.Manufacturer; distribution. (a) A manufacturer shall require that employees 
22.28 	licensed as pharmacists pursuant to chapter 151 be the only employees to give final approval 
22.29 	for the distribution of medical cannabis to a patient. A manufacturer may transport medical 
22.30 	cannabis or medical cannabis products that have been cultivated, harvested, manufactured, 
23.1 	packaged, and processed by that manufacturer to another registered manufacturer for the 
23.2 	other manufacturer to distribute.
23.3 	(b) A manufacturer may distribute medical cannabis products, whether or not the products 
23.4 	have been manufactured by that manufacturer.
23.5 	(c) Prior to distribution of any medical cannabis, the manufacturer shall:
23.6 	(1) verify that the manufacturer has received the registry verification from the 
23.7 	commissioner office for that individual patient;
23.8 	(2) verify that the person requesting the distribution of medical cannabis is the patient, 
23.9 	the patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
23.10 	listed in the registry verification using the procedures described in section 152.11, subdivision 
23.11 	2d;
23.12 	(3) assign a tracking number to any medical cannabis distributed from the manufacturer;
23.13 	(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to 
23.14 	chapter 151 has consulted with the patient to determine the proper dosage for the individual 
23.15 	patient after reviewing the ranges of chemical compositions of the medical cannabis and 
23.16 	the ranges of proper dosages reported by the commissioner office. For purposes of this 
23.17 	clause, a consultation may be conducted remotely by secure videoconference, telephone, 
23.18 	or other remote means, so long as the employee providing the consultation is able to confirm 
23.19 	the identity of the patient and the consultation adheres to patient privacy requirements that 
23.20 	apply to health care services delivered through telehealth. A pharmacist consultation under 
23.21 	this clause is not required when a manufacturer is distributing medical cannabis to a patient 
23.22 	according to a patient-specific dosage plan established with that manufacturer and is not 
23.23 	modifying the dosage or product being distributed under that plan and the medical cannabis 
23.24 	is distributed by a pharmacy technician only required:
23.25 	(i) if the patient is purchasing the product not previously purchased;
23.26 	(ii) if the patient purchases a product that the patient must administer using a different 
23.27 	method than the patient's previous method of administration;
23.28 	(iii) if the patient purchases a product with a cannabinoid concentration of at least double 
23.29 	the patient's prior dosage; and
23.30 	(iv) upon request of the patient; and
23.31 	(5) properly package medical cannabis in compliance with the United States Poison 
23.32 	Prevention Packing Act regarding child-resistant packaging and exemptions for packaging 
24.1 	for elderly patients, and label distributed medical cannabis with a list of all active ingredients 
24.2 	and individually identifying information, including:
24.3 	(i) the patient's name and date of birth;
24.4 	(ii) the name and date of birth of the patient's registered designated caregiver or, if listed 
24.5 	on the registry verification, the name of the patient's parent or legal guardian, if applicable;
24.6 	(iii) the patient's registry identification number;
24.7 	(iv) the chemical composition of the medical cannabis; and
24.8 	(v) the dosage; and.
24.9 	(6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply 
24.10 	of the dosage determined for that patient.
24.11 	(d) A manufacturer shall require any employee of the manufacturer who is transporting 
24.12 	medical cannabis or medical cannabis products to a distribution facility or to another 
24.13 	registered manufacturer to carry identification showing that the person is an employee of 
24.14 	the manufacturer.
24.15 	(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only 
24.16 	to a patient age 21 or older, or to the registered designated caregiver, parent, legal guardian, 
24.17 	or spouse of a patient age 21 or older.

24.18 	EFFECTIVE DATE. This section is effective July 1, 2024.

24.19 	Sec. 23. Minnesota Statutes 2023 Supplement, section 152.30, is amended to read:
24.20 	152.30 PATIENT DUTIES.
24.21 	(a) A patient shall apply to the commissioner for enrollment in the registry program by 
24.22 	submitting an application as required in section 152.27and an annual registration fee as 
24.23 	determined under section 152.35.
24.24 	(b) As a condition of continued enrollment, patients shall agree to:
24.25 	(1) continue to receive regularly scheduled treatment for their qualifying medical 
24.26 	condition from their health care practitioner; and
24.27 	(2) report changes in their qualifying medical condition to their health care practitioner.
24.28 	(c) A patient shall only receive medical cannabis from a registered manufacturer or 
24.29 	Tribal medical cannabis program but is not required to receive medical cannabis products 
24.30 	from only a registered manufacturer or Tribal medical cannabis program.

25.1 	EFFECTIVE DATE. This section is effective July 1, 2024.

25.2 	Sec. 24. Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 13d, is 
25.3 	amended to read:
25.4 		Subd. 13d.Drug formulary. (a) The commissioner shall establish a drug formulary. Its 
25.5 	establishment and publication shall not be subject to the requirements of the Administrative 
25.6 	Procedure Act, but the Formulary Committee shall review and comment on the formulary 
25.7 	contents.
25.8 	(b) The formulary shall not include:
25.9 	(1) drugs, active pharmaceutical ingredients, or products for which there is no federal 
25.10 	funding;
25.11 	(2) over-the-counter drugs, except as provided in subdivision 13;
25.12 	(3) drugs or active pharmaceutical ingredients when used for the treatment of impotence 
25.13 	or erectile dysfunction;
25.14 	(4) drugs or active pharmaceutical ingredients for which medical value has not been 
25.15 	established;
25.16 	(5) drugs from manufacturers who have not signed a rebate agreement with the 
25.17 	Department of Health and Human Services pursuant to section 1927 of title XIX of the 
25.18 	Social Security Act; and
25.19 	(6) medical cannabis flower as defined in section 342.01, subdivision 5416, or medical
25.20 	cannabinoid products as defined in section 342.01, subdivision 5212, or cannabis products 
25.21 	as defined in section 342.01, subdivision 20.
25.22 	(c) If a single-source drug used by at least two percent of the fee-for-service medical 
25.23 	assistance recipients is removed from the formulary due to the failure of the manufacturer 
25.24 	to sign a rebate agreement with the Department of Health and Human Services, the 
25.25 	commissioner shall notify prescribing practitioners within 30 days of receiving notification 
25.26 	from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was 
25.27 	not signed.

25.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.1 	Sec. 25. Minnesota Statutes 2023 Supplement, section 290.0132, subdivision 29, is amended 
26.2 	to read:
26.3 		Subd. 29.Disallowed section 280E expenses; cannabis licensees. The amount of 
26.4 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
26.5 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
26.6 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
26.7 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
26.8 	section 280E of the Internal Revenue Code is a subtraction.

26.9 	Sec. 26. Minnesota Statutes 2023 Supplement, section 290.0134, subdivision 19, is amended 
26.10 	to read:
26.11 		Subd. 19.Disallowed section 280E expenses; cannabis licensees. The amount of 
26.12 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
26.13 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
26.14 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
26.15 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
26.16 	section 280E of the Internal Revenue Code is a subtraction.

26.17 	Sec. 27. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 1, is amended 
26.18 	to read:
26.19 		Subdivision 1.Definitions. (a) For purposes of this section, the following terms have 
26.20 	the meanings given.
26.21 	(b) "Bundled transaction" means the retail sale of two or more products when the products 
26.22 	are otherwise distinct and identifiable and the products are sold for one nonitemized price.
26.23 	(c) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.
26.24 	(d) "Cannabis product" has the meaning given in section 342.01, subdivision 20.
26.25 	(e) "Cannabis solution product" means any cartridge, bottle, or other package that contains 
26.26 	a taxable cannabis product in a solution that is consumed or meant to be consumed through 
26.27 	the use of a heating element, power source, electronic circuit, or other electronic, chemical, 
26.28 	or mechanical means that produces vapor or aerosol. A cannabis solution product includes 
26.29 	any electronic delivery system, electronic vaping device, electronic vape pen, electronic 
26.30 	oral device, electronic delivery device, or similar product or device, and any batteries, 
26.31 	heating elements, or other components, parts, or accessories sold with and meant to be used 
26.32 	in the consumption of a solution containing a taxable cannabis product.
27.1 	(f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.
27.2 	(g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.
27.3 	(h) "Cannabis retailer" means a cannabis business licensed under section 342.32.
27.4 	(i) "Commissioner" means the commissioner of revenue.
27.5 	(j) "Gross receipts" means the total amount received in money or by barter or exchange 
27.6 	for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts 
27.7 	include but are not limited to delivery charges and packaging costs. Gross receipts do not 
27.8 	include:
27.9 	(1) any taxes imposed directly on the customer that are separately stated on the invoice, 
27.10 	bill of sale, or similar document given to the purchaser; and
27.11 	(2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party 
27.12 	and that are allowed by the seller and taken by a purchaser on a sale.
27.13 	(k) "Hemp-derived consumer product" has the meaning given in section 342.01, 
27.14 	subdivision 37.
27.15 	(l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision 
27.16 	50.
27.17 	(m) "Lower-potency hemp edible retailer" means a cannabis business licensed under 
27.18 	section 342.43, subdivision 1, clause (2).
27.19 	(n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 54.
27.20 	(o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision 
27.21 	52.
27.22 	(p) "Medical cannabis paraphernalia" has the meaning given in section 342.01, 
27.23 	subdivision 55.
27.24 	(q) (n) "Retail sale" has the meaning given in section 297A.61, subdivision 4.
27.25 	(r) (o) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis 
27.26 	solution product, hemp-derived consumer product, lower-potency hemp edible, and any 
27.27 	substantially similar item, and does not include items exempt from tax under subdivision 
27.28 	4, paragraph (b).
27.29 	(s) (p) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis 
27.30 	product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, 
28.1 	medical cannabis combination business, and lower-potency hemp edible retailer. Taxable 
28.2 	cannabis product retailer includes but is not limited to a:
28.3 	(1) retailer maintaining a place of business in this state;
28.4 	(2) marketplace provider maintaining a place of business in this state, as defined in 
28.5 	section 297A.66, subdivision 1, paragraph (a);
28.6 	(3) retailer not maintaining a place of business in this state; and
28.7 	(4) marketplace provider not maintaining a place of business in this state, as defined in 
28.8 	section 297A.66, subdivision 1, paragraph (b).

28.9 	Sec. 28. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 4, is amended 
28.10 	to read:
28.11 		Subd. 4.Exemptions. (a) The use tax imposed under subdivision 3, paragraph (a), does 
28.12 	not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable 
28.13 	cannabis products have an aggregate cost in any calendar month to the customer of $100 
28.14 	or less, and (2) the taxable cannabis products were carried into this state by the customer.
28.15 	(b) The tax imposed under this section does not apply to sales by a cannabis business 
28.16 	with a medical cannabis retail endorsement or by a medical cannabis combination business 
28.17 	of medical the following items purchased by or for a patient: cannabis flower, cannabinoid 
28.18 	products, or cannabis paraphernalia. Items sold under this paragraph must be sold to a person
28.19 	enrolled in the registry program, including medical cannabis flower, medical cannabinoid 
28.20 	products, or medical cannabis paraphernalia.
28.21 	(c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed 
28.22 	under chapter 297A are not applicable to the taxes imposed under this section.
28.23 	(d) The tax imposed under this section does not apply to:
28.24 	(1) sales made in Indian country as defined in United States Code, title 18, section 1151, 
28.25 	by a cannabis business licensed by a Minnesota Tribal government, as defined in section 
28.26 	3.9228, subdivision 1, paragraph (f); or
28.27 	(2) use tax owed on taxable cannabis products purchased on Tribally regulated land as 
28.28 	defined in section 3.9228, subdivision 1, from a cannabis business licensed by a Minnesota 
28.29 	Tribal government as defined in section 3.9228, subdivision 1, paragraph (f).

29.1 	Sec. 29. Minnesota Statutes 2023 Supplement, section 297A.67, subdivision 2, is amended 
29.2 	to read:
29.3 		Subd. 2.Food and food ingredients. Except as otherwise provided in this subdivision, 
29.4 	food and food ingredients are exempt. For purposes of this subdivision, "food" and "food 
29.5 	ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or 
29.6 	dehydrated form, that are sold for ingestion or chewing by humans and are consumed for 
29.7 	their taste or nutritional value. Food and food ingredients exempt under this subdivision do 
29.8 	not include candy, soft drinks, dietary supplements, and prepared foods. Food and food 
29.9 	ingredients do not include alcoholic beverages, tobacco, taxable cannabis products, medical 
29.10 	cannabis flower, and medical cannabinoid products and any item exempt from tax under 
29.11 	section 295.81, subdivision 4, paragraph (b). For purposes of this subdivision, "alcoholic 
29.12 	beverages" means beverages that are suitable for human consumption and contain one-half 
29.13 	of one percent or more of alcohol by volume. For purposes of this subdivision, "tobacco" 
29.14 	means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains tobacco. 
29.15 	For purposes of this subdivision, "taxable cannabis product" has the meaning given in section 
29.16 	295.81, subdivision 1, paragraph (r), "medical cannabis flower" has the meaning given in 
29.17 	section 342.01, subdivision 54, and "medical cannabinoid product" has the meaning given 
29.18 	in section 342.01, subdivision 52 (o). For purposes of this subdivision, "dietary supplements" 
29.19 	means any product, other than tobacco, intended to supplement the diet that:
29.20 	(1) contains one or more of the following dietary ingredients:
29.21 	(i) a vitamin;
29.22 	(ii) a mineral;
29.23 	(iii) an herb or other botanical;
29.24 	(iv) an amino acid;
29.25 	(v) a dietary substance for use by humans to supplement the diet by increasing the total 
29.26 	dietary intake; and
29.27 	(vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient 
29.28 	described in items (i) to (v);
29.29 	(2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form, 
29.30 	or if not intended for ingestion in such form, is not represented as conventional food and is 
29.31 	not represented for use as a sole item of a meal or of the diet; and
30.1 	(3) is required to be labeled as a dietary supplement, identifiable by the supplement facts 
30.2 	box found on the label and as required pursuant to Code of Federal Regulations, title 21, 
30.3 	section 101.36.

30.4 	Sec. 30. Minnesota Statutes 2023 Supplement, section 297A.70, subdivision 2, is amended 
30.5 	to read:
30.6 		Subd. 2.Sales to government. (a) All sales, except those listed in paragraph (b), to the 
30.7 	following governments and political subdivisions, or to the listed agencies or instrumentalities 
30.8 	of governments and political subdivisions, are exempt:
30.9 	(1) the United States and its agencies and instrumentalities;
30.10 	(2) school districts, local governments, the University of Minnesota, state universities, 
30.11 	community colleges, technical colleges, state academies, the Perpich Minnesota Center for 
30.12 	Arts Education, and an instrumentality of a political subdivision that is accredited as an 
30.13 	optional/special function school by the North Central Association of Colleges and Schools;
30.14 	(3) hospitals and nursing homes owned and operated by political subdivisions of the 
30.15 	state of tangible personal property and taxable services used at or by hospitals and nursing 
30.16 	homes;
30.17 	(4) other states or political subdivisions of other states, if the sale would be exempt from 
30.18 	taxation if it occurred in that state; and
30.19 	(5) public libraries, public library systems, multicounty, multitype library systems as 
30.20 	defined in section 134.001, county law libraries under chapter 134A, state agency libraries, 
30.21 	the state library under section 480.09, and the Legislative Reference Library.
30.22 	(b) This exemption does not apply to the sales of the following products and services:
30.23 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
30.24 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
30.25 	maximum price covering both labor and materials for use in the construction, alteration, or 
30.26 	repair of a building or facility;
30.27 	(2) construction materials purchased by tax exempt entities or their contractors to be 
30.28 	used in constructing buildings or facilities which will not be used principally by the tax 
30.29 	exempt entities;
30.30 	(3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except 
30.31 	for leases entered into by the United States or its agencies or instrumentalities;
31.1 	(4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
31.2 	prepared food, candy, soft drinks, alcoholic beverages as defined in section 297A.67, 
31.3 	subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision 
31.4 	1, paragraph (r), except for lodging, prepared food, candy, soft drinks, alcoholic beverages, 
31.5 	and taxable cannabis products purchased directly by the United States or its agencies or 
31.6 	instrumentalities; or
31.7 	(5) goods or services purchased by a local government as inputs to a liquor store, taxable 
31.8 	cannabis product retailer as defined under section 295.81, subdivision 1, paragraph (p), gas 
31.9 	or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf 
31.10 	course, marina, campground, cafe, or laundromat.
31.11 	(c) As used in this subdivision, "school districts" means public school entities and districts 
31.12 	of every kind and nature organized under the laws of the state of Minnesota, and any 
31.13 	instrumentality of a school district, as defined in section 471.59.
31.14 	(d) For purposes of the exemption granted under this subdivision, "local governments" 
31.15 	has the following meaning:
31.16 	(1) for the period prior to January 1, 2017, local governments means statutory or home 
31.17 	rule charter cities, counties, and townships; and
31.18 	(2) beginning January 1, 2017, local governments means statutory or home rule charter 
31.19 	cities, counties, and townships; special districts as defined under section 6.465; any 
31.20 	instrumentality of a statutory or home rule charter city, county, or township as defined in 
31.21 	section 471.59; and any joint powers board or organization created under section 471.59.

31.22 	Sec. 31. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 3, is amended 
31.23 	to read:
31.24 		Subd. 3.Adult-use cannabis flower. "Adult-use cannabis flower" means cannabis 
31.25 	flower that is approved for sale by the office or is substantially similar to a product approved 
31.26 	by the office. Adult-use cannabis flower does not include medical cannabis flower, hemp 
31.27 	plant parts, or hemp-derived consumer products.

31.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

31.29 	Sec. 32. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 4, is amended 
31.30 	to read:
31.31 		Subd. 4.Adult-use cannabis product. "Adult-use cannabis product" means a cannabis 
31.32 	product that is approved for sale by the office or is substantially similar to a product approved 
32.1 	by the office. Adult-use cannabis product includes edible cannabis products but does not 
32.2 	include medical cannabinoid products or lower-potency hemp edibles.

32.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

32.4 	Sec. 33. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 12, is amended 
32.5 	to read:
32.6 		Subd. 12.Cannabinoid product. "Cannabinoid product" means any of the following:
32.7 	(1) a cannabis product,;
32.8 	(2) a hemp-derived consumer product, or;
32.9 	(3) a lower-potency hemp edible; or
32.10 	(4) a product that consists of or contains cannabis concentrate or hemp concentrate or 
32.11 	is infused with cannabinoids, and is provided to:
32.12 	(i) a patient enrolled in the registry program;
32.13 	(ii) a registered designated caregiver; or
32.14 	(iii) a parent, legal guardian, or spouse of an enrolled patient, if provided by a cannabis 
32.15 	retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical 
32.16 	condition.

32.17 	Sec. 34. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended 
32.18 	to read:
32.19 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
32.20 	under this chapter:
32.21 	(1) cannabis microbusiness;
32.22 	(2) cannabis mezzobusiness;
32.23 	(3) cannabis cultivator;
32.24 	(4) cannabis manufacturer;
32.25 	(5) cannabis retailer;
32.26 	(6) cannabis wholesaler;
32.27 	(7) cannabis transporter;
32.28 	(8) cannabis testing facility;
33.1 	(9) cannabis event organizer;
33.2 	(10) cannabis delivery service; and
33.3 	(11) medical cannabis cultivator;
33.4 	(12) medical cannabis processor;
33.5 	(13) medical cannabis retailer; and
33.6 	(14) (11) medical cannabis combination business.

33.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

33.8 	Sec. 35. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 16, is amended 
33.9 	to read:
33.10 		Subd. 16.Cannabis flower. "Cannabis flower" means the harvested flower, bud, leaves, 
33.11 	and or stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and 
33.12 	medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts, 
33.13 	or hemp-derived consumer products.

33.14 	EFFECTIVE DATE. This section is effective the day following final enactment.

33.15 	Sec. 36. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended 
33.16 	to read:
33.17 		Subd. 17.Cannabis industry. "Cannabis industry" means every item, product, person, 
33.18 	process, action, business, or other thing related to cannabis plants, cannabis flower, and 
33.19 	cannabis products and subject to regulation under this chapter.

33.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

33.21 	Sec. 37. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended 
33.22 	to read:
33.23 		Subd. 19.Cannabis plant. "Cannabis plant" means all parts of the plant of the genus 
33.24 	Cannabis that is are growing or has have not been harvested and has a delta-9 
33.25 	tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis, including 
33.26 	but not limited to a mother plant; a mature, flowering plant; an immature plant; or a seedling. 
33.27 	Cannabis plant does not include industrial hemp as defined in section 18K.02, subdivision 
33.28 	3.

33.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.1 	Sec. 38. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 20, is amended 
34.2 	to read:
34.3 		Subd. 20.Cannabis product. (a) "Cannabis product" means any of the following:
34.4 	(1) cannabis concentrate;
34.5 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
34.6 	extracted or derived from cannabis plants or cannabis flower; or
34.7 	(3) any other product that contains cannabis concentrate.
34.8 	(b) Cannabis product includes adult-use cannabis products, including but not limited to 
34.9 	edible cannabis products and medical cannabinoid products. Cannabis product does not 
34.10 	include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles, 
34.11 	hemp-derived consumer products, or hemp-derived topical products.

34.12 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.13 	Sec. 39. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
34.14 	subdivision to read:
34.15 		Subd. 31a.Endorsement. "Endorsement" means an authorization from the Office of 
34.16 	Cannabis Management to conduct a specified operation activity.

34.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.18 	Sec. 40. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended 
34.19 	to read:
34.20 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
34.21 	that holds any of the following licenses:
34.22 	(1) cannabis microbusiness;
34.23 	(2) cannabis mezzobusiness;
34.24 	(3) cannabis cultivator;
34.25 	(4) cannabis manufacturer;
34.26 	(5) cannabis retailer;
34.27 	(6) cannabis wholesaler;
34.28 	(7) cannabis transporter;
34.29 	(8) cannabis testing facility;
35.1 	(9) cannabis event organizer;
35.2 	(10) cannabis delivery service;
35.3 	(11) lower-potency hemp edible manufacturer;
35.4 	(12) lower-potency hemp edible retailer; or
35.5 	(13) medical cannabis cultivator;
35.6 	(14) medical cannabis processor;
35.7 	(15) medical cannabis retailer; or
35.8 	(16) (13) medical cannabis combination business.

35.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

35.10 	Sec. 41. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended 
35.11 	to read:
35.12 		Subd. 64.Registered designated caregiver. "Registered designated caregiver" means 
35.13 	an individual who:
35.14 	(1) is at least 18 years old;
35.15 	(2) is not disqualified for a criminal offense according to rules adopted pursuant to 
35.16 	section 342.15, subdivision 2;
35.17 	(3) (2) has been approved by the Division of Medical Cannabis Office of Cannabis 
35.18 	Management to assist a patient with obtaining medical cannabis flower and medical
35.19 	cannabinoid products from a cannabis retailer or medical cannabis retailerbusiness with a 
35.20 	medical cannabis retail endorsement and with administering medical cannabis flower and 
35.21 	medical cannabinoid products; and
35.22 	(4) (3) is authorized by the Division of Medical Cannabis Office of Cannabis Management
35.23 	to assist a patient with the use of medical cannabis flower and medical cannabinoid products.

35.24 	EFFECTIVE DATE. This section is effective the day following final enactment.

35.25 	Sec. 42. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended 
35.26 	to read:
35.27 		Subd. 65.Registry or registry program. "Registry" or "registry program" means the 
35.28 	medical cannabis patient registry established under this chapter listing patients each person
35.29 	authorized to:
36.1 	(1) obtain medical cannabis flower, medical cannabinoid products, and medical cannabis 
36.2 	paraphernalia from a cannabis retailers and medical cannabis retailers business with a 
36.3 	medical cannabis retail endorsement; and
36.4 	(2) administer medical cannabis flower and medical cannabinoid products.

36.5 	EFFECTIVE DATE. This section is effective the day following final enactment.

36.6 	Sec. 43. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended 
36.7 	to read:
36.8 		Subd. 66.Registry verification. "Registry verification" means the verification provided 
36.9 	by the Division of Medical Cannabis Office of Cannabis Management that a patient is 
36.10 	enrolled in the registry program and that includes the patient's name, patient registry number, 
36.11 	and, if applicable, the name of the patient's registered designated caregiver or parent, legal 
36.12 	guardian, or spouse.

36.13 	EFFECTIVE DATE. This section is effective the day following final enactment.

36.14 	Sec. 44. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended 
36.15 	to read:
36.16 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
36.17 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
36.18 	industry and hemp consumer industry;
36.19 	(2) to establish programming, services, and notification to protect, maintain, and improve 
36.20 	the health of citizens;
36.21 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
36.22 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
36.23 	(4) to establish and regularly update standards for product manufacturing, testing, 
36.24 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
36.25 	date;
36.26 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
36.27 	a disproportionate, negative impact from cannabis prohibition;
36.28 	(6) to issue and renew licenses;
36.29 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
36.30 	including the submission of fingerprints to the Federal Bureau of Investigation where 
37.1 	required by law and to obtain criminal conviction data for individuals seeking a license 
37.2 	from the office on the individual's behalf or as a cooperative member or director, manager, 
37.3 	or general partner of a business entity;
37.4 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
37.5 	and other documents of license holders to ensure compliance with all applicable laws and 
37.6 	rules;
37.7 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
37.8 	pursuant to the office's authority;
37.9 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
37.10 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
37.11 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
37.12 	of citizens;
37.13 	(12) to make loans and grants in aid to the extent that appropriations are made available 
37.14 	for that purpose;
37.15 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
37.16 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
37.17 	cannabis industry, and the hemp consumer industry;
37.18 	(14) to provide reports as required by law;
37.19 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
37.20 	cannabis products by persons 25 years of age or younger;
37.21 	(16) to determine, based on a review of medical and scientific literature, whether it is 
37.22 	appropriate to require additional health and safety warnings containing information that is 
37.23 	both supported by credible science and helpful to consumers in considering potential health 
37.24 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
37.25 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
37.26 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
37.27 	become pregnant, and the effects that use has on brain development for individuals under 
37.28 	the age of 25;
37.29 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
37.30 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
37.31 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
37.32 	products to customers;
38.1 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
38.2 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
38.3 	with the goals identified in subdivision 1; and
38.4 	(19) to order a person or business that manufactures or produces cannabis flower, cannabis 
38.5 	products, artificially derived cannabinoids, lower-potency hemp edibles, hemp-derived 
38.6 	consumer products, or hemp-derived topical products to recall a product if the office 
38.7 	determines that the product represents a risk of causing a serious adverse incident; and
38.8 	(19) (20) to exercise other powers and authority and perform other duties required by 
38.9 	law.
38.10 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
38.11 	powers and duties until January 1, 2027:
38.12 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
38.13 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
38.14 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
38.15 	adult-use cannabis flower and adult-use cannabis products to customers; and
38.16 	(2) to permit, upon application to the office in the form prescribed by the director of the 
38.17 	office, a licensee under this chapter to perform any activity if such permission is substantially 
38.18 	necessary for the licensee to perform any other activity permitted by the applicant's license 
38.19 	and is not otherwise prohibited by law.

38.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

38.21 	Sec. 45. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 3, is amended 
38.22 	to read:
38.23 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
38.24 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
38.25 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
38.26 	15.039.
38.27 	(b) The following protections shall apply to employees who are transferred from the 
38.28 	Department of Health to the Office of Cannabis Management:
38.29 	(1) the employment status and job classification of a transferred employee shall not be 
38.30 	altered as a result of the transfer;
39.1 	(2) transferred employees who were represented by an exclusive representative prior to 
39.2 	the transfer shall continue to be represented by the same exclusive representative after the 
39.3 	transfer;
39.4 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
39.5 	continue in full force and effect for such transferred employees after the transfer;
39.6 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
39.7 	employees about any proposed changes affecting or relating to the transferred employees' 
39.8 	terms and conditions of employment to the extent such changes are not addressed in the 
39.9 	applicable collective bargaining agreement; and
39.10 	(5) for an employee in a temporary unclassified position transferred to the Office of 
39.11 	Cannabis Management, the total length of time that the employee has served in the 
39.12 	appointment shall include all time served in the appointment and the transferring agency 
39.13 	and the time served in the appointment at the Office of Cannabis Management. An employee 
39.14 	in a temporary unclassified position who was hired by a transferring agency through an 
39.15 	open competitive selection process in accordance with a policy enacted by Minnesota 
39.16 	Management and Budget shall be considered to have been hired through such process after 
39.17 	the transfer.
39.18 	(c) This subdivision is effective July 1, 2024.

39.19 	EFFECTIVE DATE. This section is effective July 1, 2024.

39.20 	Sec. 46. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 5, is amended 
39.21 	to read:
39.22 		Subd. 5.Rulemaking. (a) The office may adopt rules to implement any provisions in 
39.23 	this chapter.
39.24 	(b) Rules for which a notice of intent to adopt rules is published in the State Register 
39.25 	before July 1, 2025, may be adopted using the expedited rulemaking process in section 
39.26 	14.389. The 18-month time limit imposed by section 14.125 does not apply to rules adopted 
39.27 	under this paragraph.

39.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

40.1 	Sec. 47. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended 
40.2 	to read:
40.3 		Subd. 6.Director. (a) The governor shall appoint a director of the office with the advice 
40.4 	and consent of the senate. The director must be in the unclassified service and must serve 
40.5 	at the pleasure of the governor.
40.6 	(b) The salary of the director must not exceed the salary limit established under section 
40.7 	15A.0815, subdivision 3.
40.8 	(b) The director may appoint and employ no more than two deputy directors.
40.9 	(c) The director has administrative control of the office. The director has the powers 
40.10 	described in section 15.06, subdivision 6.
40.11 	(d) The director may apply for and accept on behalf of the state any grants, bequests, 
40.12 	gifts, or contributions for the purpose of carrying out the duties and responsibilities of the 
40.13 	director.
40.14 	(e) Pursuant to state law, the director may apply for and receive money made available 
40.15 	from federal sources for the purpose of carrying out the duties and responsibilities of the 
40.16 	director.
40.17 	(f) The director may make contracts with and grants to Tribal Nations, public and private 
40.18 	agencies, for-profit and nonprofit organizations, and individuals using appropriated money.

40.19 	Sec. 48. Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended 
40.20 	to read:
40.21 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person seeking 
40.22 	to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency 
40.23 	hemp edible, other than an edible cannabis product or lower-potency hemp edible that has 
40.24 	been placed in its final packaging, must first obtain an edible cannabinoid product handler 
40.25 	endorsement.
40.26 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
40.27 	edible cannabinoid product handler endorsement.
40.28 	(c) The office must regulate edible cannabinoid product handlers and assess penalties 
40.29 	in the same in a manner provided for consistent with Department of Agriculture regulation 
40.30 	of food handlers under chapters 28A, 31, and 34A and associated rules, with the following 
40.31 	exceptions:
41.1 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
41.2 	a license;
41.3 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
41.4 	who possess a valid license issued by the office;
41.5 	(3) the office may not charge a fee for issuing or renewing the endorsement;
41.6 	(4) the office must align the term and renewal period for edible cannabinoid product 
41.7 	handler endorsements with the term and renewal period of the license issued by the office; 
41.8 	and
41.9 	(5) an edible cannabis product or lower-potency hemp edible must not be considered 
41.10 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
41.11 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
41.12 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
41.13 	parts.
41.14 	(d) The edible cannabinoid product handler endorsement must prohibit the manufacture 
41.15 	of edible cannabis products at the same premises where food is manufactured, except for 
41.16 	the limited production of edible products produced solely for product development, sampling, 
41.17 	or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

41.18 	Sec. 49. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 1, is amended 
41.19 	to read:
41.20 		Subdivision 1.Personal adult use, possession, and transportation of cannabis flower 
41.21 	and cannabinoid products. (a) An individual 21 years of age or older may:
41.22 	(1) use, possess, or transport cannabis paraphernalia;
41.23 	(2) possess or transport two ounces or less of adult-use cannabis flower in a public place;
41.24 	(3) possess two pounds or less of adult-use cannabis flower in the individual's private 
41.25 	residence;
41.26 	(4) possess or transport eight grams or less of adult-use cannabis concentrate;
41.27 	(5) possess or transport edible cannabis products or lower-potency hemp edibles infused 
41.28 	with a combined total of 800 milligrams or less of tetrahydrocannabinol;
41.29 	(6) give for no remuneration to an individual who is at least 21 years of age:
41.30 	(i) two ounces or less of adult-use cannabis flower;
41.31 	(ii) eight grams or less of adult-use cannabis concentrate; or
42.1 	(iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams 
42.2 	or less of tetrahydrocannabinol; and
42.3 	(7) use adult-use cannabis flower and adult-use cannabis products in the following 
42.4 	locations:
42.5 	(i) a private residence, including the individual's curtilage or yard;
42.6 	(ii) on private property, not generally accessible by the public, unless the individual is 
42.7 	explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency 
42.8 	hemp edibles, or hemp-derived consumer products on the property by the owner of the 
42.9 	property; or
42.10 	(iii) on the premises of an establishment or event licensed to permit on-site consumption.
42.11 	(b) Except as provided in paragraph (c), an individual may not:
42.12 	(1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp 
42.13 	edibles, or hemp-derived consumer products if the individual is under 21 years of age;
42.14 	(2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
42.15 	consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;
42.16 	(3) use cannabis flower, cannabis products, or hemp-derived consumer products in a 
42.17 	manner that involves the inhalation of smoke, aerosol, or vapor at any location where 
42.18 	smoking is prohibited under section 144.414;
42.19 	(4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
42.20 	hemp-derived consumer products in a public school, as defined in section 120A.05, 
42.21 	subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all 
42.22 	facilities, whether owned, rented, or leased, and all vehicles that a school district owns, 
42.23 	leases, rents, contracts for, or controls;
42.24 	(5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
42.25 	hemp-derived consumer products in a state correctional facility;
42.26 	(6) operate a motor vehicle while under the influence of cannabis flower, cannabis 
42.27 	products, lower-potency hemp edibles, or hemp-derived consumer products;
42.28 	(7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp 
42.29 	edibles, or hemp-derived consumer products to an individual under 21 years of age;
42.30 	(8) give for no remuneration cannabis flower or cannabis products as a sample or 
42.31 	promotional gift if the giver is in the business of selling goods or services; or
43.1 	(9) vaporize or smoke cannabis flower, cannabis products, artificially derived 
43.2 	cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol, 
43.3 	or vapor would be inhaled by a minor.
43.4 	(c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other 
43.5 	than by smoking or by a vaporized delivery method, possession, or transportation of medical
43.6 	cannabis flower or medical cannabinoid products by a patient; a registered designated 
43.7 	caregiver; or a parent, legal guardian, or spouse of a patient.
43.8 	(d) The possession limits in paragraph (a), clauses (2) to (5), do not apply to a person 
43.9 	enrolled in the medical cannabis patient registry program under section 342.52 if the person 
43.10 	possesses cannabis flower or cannabinoid products that include patient-specific labeling 
43.11 	according to sections 342.51, subdivision 2, and 342.63, subdivision 4.
43.12 	(d) (e) A proprietor of a family or group family day care program must disclose to parents 
43.13 	or guardians of children cared for on the premises of the family or group family day care 
43.14 	program, if the proprietor permits the smoking or use of cannabis flower, cannabis products, 
43.15 	lower-potency hemp edibles, or hemp-derived consumer products on the premises outside 
43.16 	of its hours of operation. Disclosure must include posting on the premises a conspicuous 
43.17 	written notice and orally informing parents or guardians. Cannabis flower or cannabis 
43.18 	products must be inaccessible to children and stored away from food products.

43.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

43.20 	Sec. 50. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended 
43.21 	to read:
43.22 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
43.23 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
43.24 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
43.25 	manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer 
43.26 	license issued under this chapter.

43.27 	EFFECTIVE DATE. This section is effective the day following final enactment.

43.28 	Sec. 51. Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:
43.29 	342.10 LICENSES; TYPES.
43.30 	The office shall issue the following types of license:
43.31 	(1) cannabis microbusiness;
44.1 	(2) cannabis mezzobusiness;
44.2 	(3) cannabis cultivator;
44.3 	(4) cannabis manufacturer;
44.4 	(5) cannabis retailer;
44.5 	(6) cannabis wholesaler;
44.6 	(7) cannabis transporter;
44.7 	(8) cannabis testing facility;
44.8 	(9) cannabis event organizer;
44.9 	(10) cannabis delivery service;
44.10 	(11) lower-potency hemp edible manufacturer;
44.11 	(12) lower-potency hemp edible retailer; or
44.12 	(13) medical cannabis cultivator;
44.13 	(14) medical cannabis processor;
44.14 	(15) medical cannabis retailer; or
44.15 	(16) (13) medical cannabis combination business.

44.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

44.17 	Sec. 52. Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:
44.18 	342.11 LICENSES; FEES.
44.19 	(a) The office shall require the payment of application fees, initial licensing fees, and 
44.20 	renewal licensing fees as provided in this section. The initial license fee shall include the 
44.21 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
44.22 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
44.23 	Nothing in this section prohibits a local unit of government from charging the retailer 
44.24 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
44.25 	renewal licensing fees are nonrefundable.
44.26 	(b) Application and licensing fees shall be as follows:
44.27 	(1) for a cannabis microbusiness:
44.28 	(i) an application fee of $500;
45.1 	(ii) an initial license fee of $0; and
45.2 	(iii) a renewal license fee of $2,000;
45.3 	(2) for a cannabis mezzobusiness:
45.4 	(i) an application fee of $5,000;
45.5 	(ii) an initial license fee of $5,000; and
45.6 	(iii) a renewal license fee of $10,000;
45.7 	(3) for a cannabis cultivator:
45.8 	(i) an application fee of $10,000;
45.9 	(ii) an initial license fee of $20,000; and
45.10 	(iii) a renewal license fee of $30,000;
45.11 	(4) for a cannabis manufacturer:
45.12 	(i) an application fee of $10,000;
45.13 	(ii) an initial license fee of $10,000; and
45.14 	(iii) a renewal license fee of $20,000;
45.15 	(5) for a cannabis retailer:
45.16 	(i) an application fee of $2,500;
45.17 	(ii) an initial license fee of $2,500; and
45.18 	(iii) a renewal license fee of $5,000;
45.19 	(6) for a cannabis wholesaler:
45.20 	(i) an application fee of $5,000;
45.21 	(ii) an initial license fee of $5,000; and
45.22 	(iii) a renewal license fee of $10,000;
45.23 	(7) for a cannabis transporter:
45.24 	(i) an application fee of $250;
45.25 	(ii) an initial license fee of $500; and
45.26 	(iii) a renewal license fee of $1,000;
45.27 	(8) for a cannabis testing facility:
46.1 	(i) an application fee of $5,000;
46.2 	(ii) an initial license fee of $5,000; and
46.3 	(iii) a renewal license fee of $10,000;
46.4 	(9) for a cannabis delivery service:
46.5 	(i) an application fee of $250;
46.6 	(ii) an initial license fee of $500; and
46.7 	(iii) a renewal license fee of $1,000;
46.8 	(10) for a cannabis event organizer:
46.9 	(i) an application fee of $750; and
46.10 	(ii) an initial license fee of $750;
46.11 	(11) for a lower-potency hemp edible manufacturer:
46.12 	(i) an application fee of $250;
46.13 	(ii) an initial license fee of $1,000; and
46.14 	(iii) a renewal license fee of $1,000;
46.15 	(12) for a lower-potency hemp edible retailer:
46.16 	(i) an application fee of $250 per retail location;
46.17 	(ii) an initial license fee of $250 per retail location; and
46.18 	(iii) a renewal license fee of $250 per retail location; and
46.19 	(13) for a medical cannabis cultivator:
46.20 	(i) an application fee of $250;
46.21 	(ii) an initial license fee of $0; and
46.22 	(iii) a renewal license fee of $0;
46.23 	(14) for a medical cannabis processor:
46.24 	(i) an application fee of $250;
46.25 	(ii) an initial license fee of $0; and
46.26 	(iii) a renewal license fee of $0;
46.27 	(15) for a medical cannabis retailer:
47.1 	(i) an application fee of $250;
47.2 	(ii) an initial license fee of $0; and
47.3 	(iii) a renewal license fee of $0; and
47.4 	(16) (13) for a medical cannabis combination business:
47.5 	(i) an application fee of $10,000;
47.6 	(ii) an initial license fee of $20,000; and
47.7 	(iii) a renewal license fee of $70,000.

47.8 	Sec. 53. Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:
47.9 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
47.10 	(a) Licenses A person holding a license issued under this chapter may be freely transferred
47.11 	transfer that license to another entity subject to the prior written approval of the office, 
47.12 	which approval may be given or withheld in the office's sole discretion, provided that a 
47.13 	social equity applicant may only transfer the applicant's license to another social equity 
47.14 	applicant unless the license is temporary or is held by a social equity applicant. A new 
47.15 	license must be obtained when:
47.16 	(1) the form of the licensee's legal business structure converts or changes to a different 
47.17 	type of legal business structure; or
47.18 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
47.19 	or receivership proceedings; merges with another legal organization; or assigns all or 
47.20 	substantially all of its assets for the benefit of creditors.
47.21 	(b) Transfers between Notwithstanding paragraph (a), during the first three years from 
47.22 	the date that a social equity applicant holds a license, the social equity applicants applicant 
47.23 	may only transfer the license to another social equity applicant. Three years after a license 
47.24 	was initially issued, a social equity applicant may transfer the license to any entity. A license 
47.25 	transfer by a social equity applicant must be reviewed by the Division of Social Equity.
47.26 	(c) Licenses must be renewed annually.
47.27 	(d) License holders may petition the office to adjust the tier of a license issued within a 
47.28 	license category provided that the license holder meets all applicable requirements.
47.29 	(e) The office by rule may permit the relocation of a licensed cannabis business,; permit 
47.30 	the relocation of an approved operational location, including a grow or retail location; adopt 
47.31 	requirements for the submission of a license relocation application,; establish standards for 
48.1 	the approval of a relocation application,; and charge a fee not to exceed $250 for reviewing 
48.2 	and processing applications. Relocation of a licensed premises pursuant to this paragraph 
48.3 	does not extend or otherwise modify the license term of the license subject to relocation.

48.4 	Sec. 54. [342.125] TEMPORARY LICENSES.
48.5 		Subdivision 1.Temporary license. (a) The office may establish a temporary license 
48.6 	and application process for a limited number of licenses, but the office shall issue no more 
48.7 	than the following number of temporary licenses per application period:
48.8 	(1) cannabis microbusiness licenses, 100;
48.9 	(2) cannabis mezzobusiness licenses, 11;
48.10 	(3) cannabis cultivator licenses, 13;
48.11 	(4) cannabis manufacturer licenses, six;
48.12 	(5) cannabis retailer licenses, 50;
48.13 	(6) cannabis wholesaler licenses, 20;
48.14 	(7) cannabis transporter licenses, 20;
48.15 	(8) cannabis testing facility licenses, 25;
48.16 	(9) cannabis event organizer licenses, ten; and
48.17 	(10) cannabis delivery service licenses, ten.
48.18 	(b) The temporary license period begins on the day that the office issues a temporary 
48.19 	license to the applicant and is effective for 18 months after the date that the temporary 
48.20 	license was issued.
48.21 		Subd. 2.Eligibility. (a) Only a social equity applicant as described in section 342.17 or 
48.22 	a local unit of government is eligible for a temporary license.
48.23 	(b) An applicant for a temporary license must:
48.24 	(1) complete an initial application according to section 342.14, subdivision 1, on a form 
48.25 	approved by the office; and
48.26 	(2) pay the application fee required by section 342.11, paragraph (b), to the office.
48.27 	(c) As part of the application process, the office must verify the applicant's status as a 
48.28 	social equity applicant.
49.1 	(d) The office may not issue a temporary license in violation of section 342.18, 
49.2 	subdivision 2.
49.3 	(e) The office shall not require an applicant to possess or own any property on which or 
49.4 	facility in which to operate a cannabis business at the time of the initial application.
49.5 		Subd. 3.Application process. (a) The office must announce the commencement of a 
49.6 	temporary license application period at least 14 days before the date that the office begins 
49.7 	to accept applications for temporary licenses. The announcement must include:
49.8 	(1) the types of licenses that are available during the temporary license application 
49.9 	period;
49.10 	(2) the number of licenses available by license type;
49.11 	(3) the date on which the temporary license application period will begin; and
49.12 	(4) the date on which the temporary license application period will end.
49.13 	(b) The office must accept applications for temporary licenses for 30 calendar days 
49.14 	during a temporary license application period.
49.15 	(c) The office may deny an application for a temporary license that:
49.16 	(1) is incomplete;
49.17 	(2) contains a materially false statement about the applicant or omits material information 
49.18 	about the applicant;
49.19 	(3) fails to meet the minimum qualifications for the license in section 342.18, subdivision 
49.20 	3; or
49.21 	(4) is not submitted by the deadline established by the office.
49.22 	(d) The office may request additional information from any applicant if the office 
49.23 	determines that the information is necessary to review or process the application. If the 
49.24 	applicant does not provide the additional requested information within 14 calendar days, 
49.25 	the office may deny the application.
49.26 		Subd. 4.Lottery. (a) If the number of available temporary licenses is less than the 
49.27 	number of social equity applicants qualified for temporary licenses, the office must conduct 
49.28 	a lottery. The lottery must be impartial, random, and in a format determined by the office.
49.29 	(b) The office must include in the lottery any social equity applicant that meets the 
49.30 	requirements under subdivisions 2 and 3.
50.1 	(c) The office may rescind a social equity applicant's status as a selected lottery applicant 
50.2 	if:
50.3 	(1) there are grounds for revocation under section 342.21;
50.4 	(2) the social equity applicant is disqualified under section 342.15; or
50.5 	(3) the social equity applicant is determined to be in arrears on property, business, or 
50.6 	personal taxes.
50.7 		Subd. 5.Local unit of government. The office shall only issue a temporary license to 
50.8 	a local unit of government if, after assigning temporary licenses to social equity applicants, 
50.9 	there are remaining temporary licenses. A temporary license held by a local unit of 
50.10 	government must not count towards the limited number of licenses issued by a local 
50.11 	government unit under section 342.13, paragraph (h).
50.12 		Subd. 6.Authority and restrictions. (a) The holder of a temporary license may take 
50.13 	the necessary steps to prepare for business operations, including:
50.14 	(1) establishing legal control of the site of the cannabis business through lease, purchase, 
50.15 	or other means;
50.16 	(2) gaining zoning or planning approval for the site of the cannabis business from a local 
50.17 	unit of government; or
50.18 	(3) raising capital for the license holder's business operations.
50.19 	(b) The holder of a temporary license shall not:
50.20 	(1) engage in purchasing, possessing, cultivating, manufacturing, or selling cannabis or 
50.21 	cannabis products;
50.22 	(2) grow, process, distribute, dispense, or otherwise handle cannabis;
50.23 	(3) make any change or transfer of ownership or control that would require a new business 
50.24 	registration with the secretary of state; or
50.25 	(4) make any transfer of ownership interest that causes the holder of the temporary 
50.26 	license to no longer qualify as a social equity applicant as defined in section 342.17.
50.27 		Subd. 7.Revocation and other penalties. (a) The office may revoke a temporary license 
50.28 	if the holder of the temporary license or, if the license holder is a business entity, any 
50.29 	cooperative member or director, manager, or general partner of the business entity:
50.30 	(1) fraudulently or deceptively obtained the temporary license;
50.31 	(2) fails to reveal any material fact pertaining to the licensee's qualification for a license;
51.1 	(3) fails to convert a temporary license into a license that is not temporary within 18 
51.2 	months of the date that the temporary license was issued;
51.3 	(4) violates this chapter;
51.4 	(5) is not registered or in good standing with the Office of the Secretary of State; or
51.5 	(6) is in arrears on property, business, or personal taxes.
51.6 		Subd. 8.Conversion of temporary license. (a) The office must convert a temporary 
51.7 	license into a license after the office:
51.8 	(1) adopts initial rules pursuant to section 342.02, subdivision 5; and
51.9 	(2) finds that the license holder or, if the license holder is a business entity, every 
51.10 	cooperative member or director, manager, or general partner of the business entity, has not 
51.11 	violated this chapter.
51.12 	(b) The office must not convert a temporary license into a license that is not temporary 
51.13 	if the ownership of the temporary license holder's business has changed since being granted 
51.14 	a temporary license and the temporary license holder has not filed an updated ownership 
51.15 	disclosure with information consistent with the original application and section 342.14, 
51.16 	subdivision 1, paragraph (b).
51.17 	(c) The office must not convert a temporary license into a license if the cannabis business 
51.18 	for which the license is held does not meet local zoning and land use laws.
51.19 	(d) A license that is converted from a temporary license according to this subdivision 
51.20 	expires 18 months after the date of the conversion.
51.21 		Subd. 9.Applicants; right to a reconsideration. (a) An applicant that is not issued a 
51.22 	temporary license or an applicant that the office has not entered into the lottery may request 
51.23 	a records review of the submitted application within seven calendar days of receiving 
51.24 	notification that the application does not meet the minimum qualifications for a license 
51.25 	under section 342.18, subdivision 3.
51.26 	(b) Upon an applicant's request, the office must allow the applicant to examine the 
51.27 	applicant's records received by the office.
51.28 	(c) If the office determines that an applicant is ineligible for a temporary license, the 
51.29 	office must inform the applicant of any reasons that form the basis of the office's 
51.30 	determination.
51.31 	(d) The following applicants may request reconsideration by the director:
52.1 	(1) an applicant selected in a lottery whose license is later revoked by the office; or
52.2 	(2) an applicant who previously held a temporary license until the temporary license 
52.3 	was revoked by the office.
52.4 	(e) An applicant who does not meet the minimum qualifications for a license under 
52.5 	section 342.18, subdivision 3, and is not selected in the lottery may not request 
52.6 	reconsideration.
52.7 		Subd. 10.Multiple lotteries; application retention. (a) Upon receiving notification 
52.8 	that an applicant was not selected in the lottery, the applicant may request that the office 
52.9 	retain the applicant's application for subsequent lotteries.
52.10 	(b) The office must retain any application requested for retention under paragraph (a) 
52.11 	for one year after the date of the request.
52.12 	(c) The office may contact an applicant with a retained application for any additional 
52.13 	information required for a subsequent lottery.
52.14 	(d) Any application retained by the office that meets the specifications and requirements 
52.15 	of a subsequent lottery within the one-year retention period, may be entered into the lottery 
52.16 	if the applicant:
52.17 	(1) pays the relevant application fee;
52.18 	(2) amends the application upon the request of the office; and
52.19 	(3) provides the office with any additional information requested by the office.
52.20 	(e) The office must not enter a retained application into a subsequent lottery if the 
52.21 	applicant or, if the applicant is a business entity, any cooperative member or director, 
52.22 	manager, or general partner of the business entity has violated this chapter.

52.23 	EFFECTIVE DATE. This section is effective the day following final enactment.

52.24 	Sec. 55. Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:
52.25 	342.13 LOCAL CONTROL.
52.26 	(a) A local unit of government may not prohibit the possession, transportation, or use 
52.27 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
52.28 	consumer products authorized under this chapter.
52.29 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
52.30 	the establishment or operation of a cannabis business licensed under this chapter.
53.1 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
53.2 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
53.3 	the establishment or operation of cannabis businesses. A local unit of government may 
53.4 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
53.5 	day care, residential treatment facility, or an attraction within a public park that is regularly 
53.6 	used by minors, including a playground or athletic field.
53.7 	(d) The office shall work with local units of government to:
53.8 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
53.9 	of the operation of a cannabis business;
53.10 	(2) develop standardized forms and procedures for the issuance of a retail registration 
53.11 	pursuant to section 342.22; and
53.12 	(3) develop model policies and procedures for the performance of compliance checks 
53.13 	required under section 342.22.
53.14 	(e) If a local unit of government is conducting studies or has authorized a study to be 
53.15 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
53.16 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
53.17 	a cannabis business, the governing body of the local unit of government may adopt an 
53.18 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
53.19 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
53.20 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
53.21 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
53.22 	or a portion thereof until January 1, 2025.
53.23 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
53.24 	government shall certify on a form provided by the office whether a proposed cannabis 
53.25 	business complies with local zoning ordinances and, if applicable, whether the proposed 
53.26 	business complies with the state fire code and building code. The office may not issue a 
53.27 	licensean endorsement to a cannabis business if a the cannabis business does not meet local 
53.28 	zoning and land use laws.
53.29 	(g) Upon receipt of an application for a license issued under this chapter, the office shall 
53.30 	contact the local unit of government in which the business would be located and provide 
53.31 	the local unit of government with 30 days in which to provide input on the application. The 
53.32 	local unit of government may provide the office with any additional information it believes 
53.33 	is relevant to the office's decision on whether to issue a license, including but not limited 
54.1 	to identifying concerns about the proposed location of a cannabis business or sharing public 
54.2 	information about an applicant.
54.3 	(h) (g) The office by rule shall establish an expedited complaint process to receive, 
54.4 	review, and respond to complaints made by a local unit of government about a cannabis 
54.5 	business. Complaints may include alleged violations of local ordinances or other alleged 
54.6 	violations. At a minimum, the expedited complaint process shall require the office to provide 
54.7 	an initial response to the complaint within seven days and perform any necessary inspections 
54.8 	within 30 days. Nothing in this paragraph prohibits a local unit of government from enforcing 
54.9 	a local ordinance. If a local unit of government notifies the office that a cannabis business 
54.10 	other than a cannabis retailer, cannabis microbusiness with a retail operations endorsement, 
54.11 	cannabis mezzobusiness, lower-potency hemp edible retailer, medical cannabis retailer, or 
54.12 	medical cannabis combination business poses an immediate threat to the health or safety 
54.13 	of the public, the office must respond within one business day and may take any action 
54.14 	described in section 342.19 or 342.21.
54.15 	(i) (h) A local government unit that issues cannabis retailer registration under section 
54.16 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
54.17 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
54.18 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
54.19 	(j) (i) If a county has one active registration for every 12,500 residents, a city or town 
54.20 	within the county is not obligated to register a cannabis business.
54.21 	(k) (j) Nothing in this section shall prohibit a local government unit from allowing 
54.22 	licensed cannabis retailers in excess of the minimums set in paragraph (i) (h).
54.23 	(l) (k) Notwithstanding the foregoing provisions, the state shall not issue a license to 
54.24 	any cannabis business to operate in Indian country, as defined in United States Code, title 
54.25 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
54.26 	government.

54.27 	Sec. 56. Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:
54.28 	342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.
54.29 		Subdivision 1.Application; contents. (a) The office by rule shall establish forms and 
54.30 	procedures for the processing of cannabis licenses issued under this chapter. At a minimum, 
54.31 	any application to obtain or renew a cannabis license shall The office may direct an applicant 
54.32 	to include the following information, if applicable in an application to obtain or renew a 
54.33 	cannabis license:
55.1 	(1) the name, address, and date of birth of the applicant;
55.2 	(2) the disclosure of ownership and control required under paragraph (b);
55.3 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
55.4 	director, manager, and general partner of the business has ever filed for bankruptcy;
55.5 	(4) the address and legal property description of the business, if applicable, except an 
55.6 	applicant is not required to secure a physical premises for the business at the time of 
55.7 	application;
55.8 	(5) a general description of the location or locations that the applicant plans to operate, 
55.9 	including the planned square feet of planned space for cultivation, wholesaling, and retailing, 
55.10 	as applicable;
55.11 	(6) a copy of the security plan;
55.12 	(7) proof of trade name registration;
55.13 	(8) a copy of the applicant's business plan showing the expected size of the business; 
55.14 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
55.15 	applicant and any officer, director, manager, and general partner of the business; the 
55.16 	environmental plan; and other relevant financial and operational components;
55.17 	(9) an attestation signed by a bona fide labor organization stating that the applicant has 
55.18 	entered into a labor peace agreement;
55.19 	(10) certification that the applicant will comply with the requirements of this chapter 
55.20 	relating to the ownership and operation of a cannabis business;
55.21 	(11) identification of one or more controlling persons or managerial employees as agents 
55.22 	who shall be responsible for dealing with the office on all matters; and
55.23 	(12) a statement that the applicant agrees to respond to the office's supplemental requests 
55.24 	for information.
55.25 	(b) An applicant must file and update as necessary a disclosure of ownership and control. 
55.26 	The office by rule shall establish the contents and form of the disclosure. Except as provided 
55.27 	in paragraph (f), the disclosure shall, at a minimum, include the following:
55.28 	(1) the management structure, ownership, and control of the applicant or license holder, 
55.29 	including the name of each cooperative member, officer, director, manager, general partner, 
55.30 	or business entity; the office or position held by each person; each person's percentage 
55.31 	ownership interest, if any; and, if the business has a parent company, the name of each 
56.1 	owner, board member, and officer of the parent company and the owner's, board member's, 
56.2 	or officer's percentage ownership interest in the parent company and the cannabis business;
56.3 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
56.4 	director, manager, and general partner of the business, indicating whether that person has 
56.5 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
56.6 	any other state or territory of the United States, or any other country;
56.7 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
56.8 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
56.9 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
56.10 	(5) copies of any promissory notes, security instruments, or other similar agreements;
56.11 	(6) an explanation detailing the funding sources used to finance the business;
56.12 	(7) a list of operating and investment accounts for the business, including any applicable 
56.13 	financial institution and account number; and
56.14 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
56.15 	including the loan amount, loan terms, and name and address of the creditor.
56.16 	(c) An application may include:
56.17 	(1) proof that the applicant is a social equity applicant;
56.18 	(2) a description of the training and education that will be provided to any employee; 
56.19 	or
56.20 	(3) a copy of business policies governing operations to ensure compliance with this 
56.21 	chapter.
56.22 	(d) Commitments made by an applicant in its application, including but not limited to 
56.23 	the maintenance of a labor peace agreement, shall be an ongoing material condition of 
56.24 	maintaining and renewing the license.
56.25 	(e) An application on behalf of a corporation or association shall be signed by at least 
56.26 	two officers or managing agents of that entity.
56.27 	(f) The office may, by rule, establish exceptions to the disclosures required under 
56.28 	paragraph (b) for members of a cooperative who hold less than a five percent ownership 
56.29 	interest in the cooperative.
56.30 		Subd. 2.Application; process. (a) An applicant must submit all required information 
56.31 	to the office on the forms and in the manner prescribed by the office.
57.1 	(b) If the office receives an application that fails to provide the required information, 
57.2 	the office shall issue a deficiency notice to the applicant. The applicant shall have ten 
57.3 	business days from the date of the deficiency notice to submit the required information.
57.4 	(c) Failure by an applicant to submit all required information will result in the application 
57.5 	being rejected.
57.6 	(d) Upon receipt of a completed application and fee, the office shall forward a copy of 
57.7 	the application to the local unit of government in which the business operates or intends to 
57.8 	operate with a form for certification as to whether a proposed cannabis business complies 
57.9 	with local zoning ordinances and, if applicable, whether the proposed business complies 
57.10 	with the state fire code and building code.
57.11 	(e) (d) Within 90 days of receiving a completed application and the results of any required 
57.12 	criminal history check, the office shall issue the appropriate license or send the applicant a 
57.13 	notice of rejection setting forth specific reasons that the office did not approve the application.
57.14 		Subd. 3.License revocation. The office may revoke a cannabis business license if the 
57.15 	licensee has not made good faith efforts to obtain an endorsement within 18 months of the 
57.16 	date that the license was issued. The office may give a licensee a onetime extension to obtain 
57.17 	an endorsement if the licensee demonstrates that the licensee made good faith efforts to 
57.18 	obtain an endorsement within 18 months of the date that the license was issued.

57.19 	Sec. 57. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 1, is amended 
57.20 	to read:
57.21 		Subdivision 1.Criminal history check. (a) Upon request by the office, every license 
57.22 	applicant, license holder, or, in the case of a business entity, every individual responsible 
57.23 	for conducting the affairs of the entity, including but not limited to every owner and every 
57.24 	cooperative member or director, manager, and general partner of the business entity, for a 
57.25 	cannabis business license, or in the case of a business entity, every cooperative member or 
57.26 	director, manager, and general partner of the business entity, and prospective cannabis 
57.27 	worker must submit a completed criminal history records check consent form, a full set of 
57.28 	classifiable fingerprints, and the required fees to the office. Upon receipt of this information, 
57.29 	the office must submit the completed criminal history records check consent form, full set 
57.30 	of classifiable fingerprints, and required fees to the Bureau of Criminal Apprehension.
57.31 	(b) After receiving this information, the bureau must conduct a Minnesota state criminal 
57.32 	history records check of the license applicant or prospective cannabis worker an individual 
57.33 	identified in paragraph (a). The bureau may exchange a license applicant's or prospective 
58.1 	cannabis worker's an individual's fingerprints with the Federal Bureau of Investigation to 
58.2 	obtain the license applicant's or prospective cannabis worker's national criminal history 
58.3 	record information of the individual. The bureau must return the results of the Minnesota
58.4 	state and federal criminal history records checks to the office to determine if the license 
58.5 	applicant or prospective cannabis worker individual is disqualified under rules adopted 
58.6 	pursuant to this section.
58.7 	(b)(c) The office may, by rule, establish exceptions to the requirement under paragraph
58.8 	paragraphs (a) and (b) for members of a cooperative who hold less than a five percent 
58.9 	ownership interest in the cooperative.

58.10 	Sec. 58. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 2, is amended 
58.11 	to read:
58.12 		Subd. 2.Criminal offenses; disqualifications. The office may by rule determine whether 
58.13 	any felony convictions shall, including but not limited to convictions for noncannabis 
58.14 	controlled substance crimes in the first or second degree, human trafficking, labor trafficking, 
58.15 	fraud, or financial crimes, disqualify a person an individual from holding or receiving a 
58.16 	cannabis business license issued under this chapter or working for a cannabis business, and 
58.17 	the length of any such disqualification. In adopting rules pursuant to this subdivision, the 
58.18 	office shall not disqualify a person an individual for a violation of section 152.025.

58.19 	Sec. 59. Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a 
58.20 	subdivision to read:
58.21 		Subd. 5.Civil and regulatory offenses; disqualifications. The office may determine 
58.22 	whether any civil or regulatory violations, as determined by another state agency, local unit 
58.23 	of government, or any other jurisdiction, disqualify an individual from holding or receiving 
58.24 	a cannabis business license issued under this chapter or disqualify an individual from working 
58.25 	for a cannabis business, and the length of the disqualification. Upon the office's request, a 
58.26 	state agency, as defined in section 13.02, subdivision 17, may release civil investigative 
58.27 	data, including data classified as protected nonpublic or confidential under section 13.39, 
58.28 	subdivision 2, if the request is related to a specific applicant and the data is necessary to 
58.29 	make a determination under this section.

58.30 	Sec. 60. [342.151] EMPLOYEES OF LICENSE HOLDERS.
58.31 		Subdivision 1.Criminal history check. A license holder may employ or contract with 
58.32 	as many unlicensed individuals as may be necessary, provided that the license holder is at 
59.1 	all times accountable for the good conduct of every individual employed by or contracted 
59.2 	with the license holder. Before hiring an individual as a cannabis worker, the license holder 
59.3 	must submit to the Bureau of Criminal Apprehension the individual's full set of fingerprints 
59.4 	and written consent for the bureau to conduct a state and national criminal history check. 
59.5 	The bureau may exchange an individual's fingerprints with the Federal Bureau of 
59.6 	Investigation. The Bureau of Criminal Apprehension must determine whether the individual 
59.7 	is qualified to be employed as a cannabis worker and must notify the license holder of the 
59.8 	bureau's determination. The license holder must not employ an individual who is disqualified 
59.9 	from being employed as a cannabis worker.
59.10 		Subd. 2.Disqualification. (a) A license holder must not employ an individual as a 
59.11 	cannabis worker if the individual has been convicted of any of the following crimes that 
59.12 	would constitute a felony:
59.13 	(1) human trafficking;
59.14 	(2) noncannabis controlled substance crimes in the first or second degree;
59.15 	(3) labor trafficking;
59.16 	(4) fraud;
59.17 	(5) embezzlement;
59.18 	(6) extortion;
59.19 	(7) money laundering; or
59.20 	(8) insider trading;
59.21 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
59.22 	has not been granted.
59.23 	(b) A license holder must not employ an individual as a cannabis worker if the individual 
59.24 	made any false statement in an application for employment.

59.25 	Sec. 61. Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:
59.26 	342.17 SOCIAL EQUITY APPLICANTS.
59.27 	(a) An applicant qualifies as a social equity applicant if the applicant:
59.28 	(1) was convicted of an offense involving the possession or sale of cannabis or marijuana 
59.29 	prior to May 1, 2023;
60.1 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
60.2 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
60.3 	(3) was a dependent of an individual who was convicted of an offense involving the 
60.4 	possession or sale of cannabis or marijuana prior to May 1, 2023;
60.5 	(4) is a military veteran, including status as a service-disabled veteran, current or former 
60.6 	member of the national guard, or;
60.7 	(5) any military veteran or current or former member of the national guard who lost 
60.8 	honorable status due to an offense involving the possession or sale of cannabis or marijuana;
60.9 	(5) (6) has been a resident for the last five years of one or more subareas, such as census 
60.10 	tracts or neighborhoods, that experienced a disproportionately large amount of cannabis 
60.11 	enforcement as determined by the study conducted by the office pursuant to section 342.04, 
60.12 	paragraph (b), and reported in the preliminary report, final report, or both;
60.13 	(6) is an emerging farmer as defined in section 17.055, subdivision 1; or
60.14 	(7) is currently a farmer or an aspiring cannabis farmer who faces barriers to education 
60.15 	or employment; or
60.16 	(7) (8) has been a resident for the last five years of one or more census tracts where, as 
60.17 	reported in the most recently completed decennial census published by the United States 
60.18 	Bureau of the Census, either:
60.19 	(i) the poverty rate was 20 percent or more; or
60.20 	(ii) the median family income did not exceed 80 percent of statewide median family 
60.21 	income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide 
60.22 	median family income or 80 percent of the median family income for that metropolitan 
60.23 	area.
60.24 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
60.25 	in the case of a business entity, every cooperative member or director, manager, and general 
60.26 	partner apply to at least 65 percent of the controlling ownership of the business entity.

60.27 	Sec. 62. [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
60.28 		Subdivision 1.Social equity license classification. (a) The office must make a social 
60.29 	equity classification available to a social equity applicant under section 342.17.
60.30 	(b) The office must classify any type of license under section 342.10 as a social equity 
60.31 	license if the license is held by a social equity applicant.
61.1 		Subd. 2.Social equity applicants; temporary licenses. After accepting and reviewing 
61.2 	an application for a license from a social equity applicant, the office may issue a temporary 
61.3 	license according to section 342.125 to the social equity applicant.

61.4 	Sec. 63. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended 
61.5 	to read:
61.6 		Subd. 3.Application score; license priority review. (a) The office shall award points 
61.7 	to review each completed application for a license to operate a cannabis business in the 
61.8 	following categories:
61.9 	(1) status as a social equity applicant or as an applicant who is substantially similar to 
61.10 	a social equity applicant as described in paragraph (c);
61.11 	(2) status as a veteran or retired national guard applicant who does not meet the definition 
61.12 	of social equity applicant;
61.13 	(3) (1) security and record keeping;
61.14 	(4) (2) employee training plan;
61.15 	(5) (3) business plan and financial situation;
61.16 	(6) (4) labor and employment practices;
61.17 	(7) (5) knowledge and experience; and
61.18 	(8) (6) environmental plan.
61.19 	(b) The office may award additional points to an application if the license holder would 
61.20 	expand service to an underrepresented market, including but not limited to participation in 
61.21 	the medical cannabis program.
61.22 	(c) The office shall establish application materials permitting individual applicants to 
61.23 	demonstrate the impact that cannabis prohibition has had on that applicant, including but 
61.24 	not limited to the arrest or imprisonment of the applicant or a member of the applicant's 
61.25 	immediate family, and the office may award points to such applicants in the same manner 
61.26 	as points are awarded to social equity applicants.
61.27 	(d) (b) The office shall by rule establish policies and guidelines, which the office must 
61.28 	be made make available to the public, regarding the number of points available minimum 
61.29 	qualifications in each category and the basis for awarding those points. Status as a social 
61.30 	equity applicant must account for at least 20 percent of the total available points. In 
61.31 	determining the number of points to award to a cooperative or business applying as a social 
62.1 	equity applicant, the office shall consider the number or ownership percentage of cooperative 
62.2 	members, officers, directors, managers, and general partners who qualify as social equity 
62.3 	applicants criteria that the office uses to determine whether an applicant meets the minimum 
62.4 	qualifications in each category.
62.5 	(e) Consistent with the goals identified in subdivision 1, the office shall issue licenses 
62.6 	in each license category, giving priority to applicants who receive the highest score under 
62.7 	paragraphs (a) and (b). If there are insufficient licenses available for entities that receive 
62.8 	identical scores, the office shall utilize a lottery to randomly select license recipients from 
62.9 	among those entities.

62.10 	Sec. 64. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
62.11 	subdivision to read:
62.12 		Subd. 4.Maximum number of licenses. (a) Through as many licensing periods as the 
62.13 	office deems necessary, the office shall issue no more than the maximum number of licenses 
62.14 	in each license category listed in paragraphs (e) and (f) to applicants that meet the minimum 
62.15 	qualifications in subdivision 3. After 24 months from the beginning of the license application 
62.16 	process, the office may adjust the maximum number of licenses of any type listed in this 
62.17 	subdivision based on market demand, consistent with the objectives in section 342.02, 
62.18 	subdivision 1, and the annual report required under section 342.04, paragraph (f).
62.19 	(b) If there are insufficient licenses available for all applicants that meet the minimum 
62.20 	qualifications in subdivision 3, the office shall hold a lottery to randomly select license 
62.21 	recipients from among the applicants. The office may issue as many licenses as the office 
62.22 	deems necessary of a license type that is not listed in this subdivision. The office is not 
62.23 	required to issue a license for a license type that is not listed in this subdivision.
62.24 	(c) Cannabis microbusiness and cannabis mezzobusiness license holders with a retail 
62.25 	endorsement must obtain at least one other endorsement for authorized actions under the 
62.26 	license category within 18 months of license issuance or the office may revoke the license 
62.27 	holder's license or take appropriate enforcement action.
62.28 	(d) The office is not required to issue licenses to meet the maximum number of licenses 
62.29 	that may be issued under paragraphs (e) and (f).
62.30 	(e) For licenses that are available to social equity applicants, the maximum number of 
62.31 	licenses that the office may issue are:
62.32 	(1) cultivator licenses, 25;
62.33 	(2) product manufacturer licenses, 12;
63.1 	(3) retailer licenses, 100; and
63.2 	(4) cannabis mezzobusiness licenses, 22.
63.3 	(f) For licenses that are available to all applicants, the maximum number of licenses that 
63.4 	the office may issue are:
63.5 	(1) cultivator licenses, 25;
63.6 	(2) product manufacturer licenses, 12;
63.7 	(3) retailer licenses, 100; and
63.8 	(4) cannabis mezzobusiness licenses, 22.

63.9 	Sec. 65. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
63.10 	subdivision to read:
63.11 		Subd. 5.Conversion to hemp business license. (a) After the office adopts initial rules 
63.12 	pertaining to cannabis, the office may permit a holder of a hemp-derived cannabinoid 
63.13 	business registration pursuant to section 151.72 to convert the holder's registration to a 
63.14 	comparable lower-potency hemp edible business license if:
63.15 	(1) the registration was active before the office adopted initial rules pertaining to cannabis;
63.16 	(2) the registrant submits documentation to the office sufficient to meet the minimum 
63.17 	requirements in section 342.44;
63.18 	(3) the registrant pays an application and licensing fee as required by section 342.11; 
63.19 	and
63.20 	(4) the registrant is in good standing with the state.
63.21 	(b) A registrant with an active hemp-derived cannabinoid business registration pursuant 
63.22 	to section 151.72 may continue operations under an active registration for no more than 30 
63.23 	days after the office begins accepting applications for a lower-potency hemp edible business 
63.24 	license.
63.25 	(c) Upon the submission of an application for a lower-potency hemp edible business 
63.26 	license to the office, a registrant's hemp-derived cannabinoid business registration shall 
63.27 	remain active until the office makes a determination regarding the registrant's application, 
63.28 	as long as the registrant remains in good standing with the state.

64.1 	Sec. 66. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 1, is amended 
64.2 	to read:
64.3 		Subdivision 1.Authority to inspect. (a) In order to carry out the purposes of this chapter, 
64.4 	the office, upon presenting appropriate credentials to the owner, operator, or agent in charge, 
64.5 	is authorized to:
64.6 	(1) enter any cannabis business or hemp business the place of business of any cannabis 
64.7 	business, hemp business, or business engaged in the cultivation, manufacture, or retail sale 
64.8 	of cannabis without a license under this chapter without delay and at reasonable times;
64.9 	(2) inspect and investigate during regular working hours and at other reasonable times, 
64.10 	within reasonable limits and in a reasonable manner, any cannabis business or hemp business
64.11 	the place of business of any cannabis business, hemp business, or business engaged in the 
64.12 	cultivation, manufacture, or retail sale of cannabis without a license under this chapter and 
64.13 	all relevant conditions, equipment, records, and materials therein; and
64.14 	(3) question privately any employer, owner, operator, agent, or employee of a cannabis 
64.15 	business or hemp business any cannabis business, hemp business, or business engaged in 
64.16 	the cultivation, manufacture, or retail sale of cannabis without a license under this chapter.
64.17 	(b) An employer, owner, operator, agent, or employee must not refuse the office entry 
64.18 	or otherwise deter or prohibit the office from taking action under paragraph (a).

64.19 	Sec. 67. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 3, is amended 
64.20 	to read:
64.21 		Subd. 3.Aiding of inspection. Subject to rules issued by the office, a representative of 
64.22 	a cannabis business or hemp business shall business participating in the cannabis industry 
64.23 	or hemp consumer industry must be given an opportunity to accompany the office during 
64.24 	the physical inspection of any cannabis business or hemp the business for the purpose of 
64.25 	aiding such inspection.

64.26 	Sec. 68. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 4, is amended 
64.27 	to read:
64.28 		Subd. 4.Complaints and reports; priority of inspection. (a) The office may conduct 
64.29 	inspections of any licensed cannabis business or hemp business cannabis business, hemp 
64.30 	business, or a business engaged in the cultivation, manufacture, or retail sale of cannabis 
64.31 	without a license under this chapter at any time to ensure compliance with the ownership 
64.32 	and operation requirements of this chapter.
65.1 	(b) Any person may report a suspected violation of a safety or health standard. If upon 
65.2 	receipt of such notification the office determines that there are reasonable grounds to believe 
65.3 	that such violation or danger exists, the office shall make a special inspection as soon as 
65.4 	practicable to determine if such danger or violation exists.
65.5 	(c) The office shall prioritize inspections of cannabis businesses and hemp businesses
65.6 	where there are reasonable grounds to believe that a violation by a person or business poses 
65.7 	imminent danger to the public or customers. Inspections must take place within one business 
65.8 	day of the receipt of a credible report.
65.9 	(d) The office shall promptly inspect cannabis businesses and hemp businesses the place 
65.10 	of business of any cannabis business, hemp business, or a business engaged in the cultivation, 
65.11 	manufacture, or retail sale of cannabis without a license under this chapter that are is the 
65.12 	subject of complaint by a local unit of government.

65.13 	Sec. 69. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 5, is amended 
65.14 	to read:
65.15 		Subd. 5.Violations; administrative orders and penalties. (a) The office may issue an 
65.16 	administrative order to any licensed cannabis business or hemp business cannabis business, 
65.17 	hemp business, or a business engaged in the cultivation, manufacture, or retail sale of 
65.18 	cannabis without a license under this chapter that the office determines has committed a 
65.19 	violation of this chapter or rules adopted pursuant to this chapter. The administrative order 
65.20 	may require the business to correct the violation or to cease and desist from committing the 
65.21 	violation. The order must state the deficiencies that constitute the violation and the time by 
65.22 	which the violation must be corrected. If the business believes that the information in the 
65.23 	administrative order is in error, the business may ask the office to consider the parts of the 
65.24 	order that are alleged to be in error. The request must be in writing, delivered to the office 
65.25 	by certified mail within seven days after receipt of the order, and provide documentation 
65.26 	to support the allegation of error. The office must respond to a request for reconsideration 
65.27 	within 15 days after receiving the request. A request for reconsideration does not stay the 
65.28 	correction order unless the office issues a supplemental order granting additional time. The 
65.29 	office's disposition of a request for reconsideration is final.
65.30 	(b) For each violation of this chapter or rules adopted pursuant to this chapter, the office 
65.31 	may issue to each cannabis business or hemp individual or business a monetary penalty of 
65.32 	up to $10,000, an amount that deprives the individual or business of any economic advantage 
65.33 	gained by the violation, or both.
66.1 	(c) An administrative penalty may be recovered in a civil action in the name of the state 
66.2 	brought in the district court of the county where the violation is alleged to have occurred 
66.3 	or the district court where the office is housed.
66.4 	(d) In addition to penalties listed in this subdivision, a person or business who violates 
66.5 	the provisions of this chapter is subject to any applicable criminal penalty.

66.6 	Sec. 70. Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:
66.7 	342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.
66.8 		Subdivision 1.Registration required. Before receiving a retail operations endorsement 
66.9 	and making retail sales to customers or patients, a cannabis microbusiness with a retail 
66.10 	operations endorsement, cannabis mezzobusiness with a retail operations endorsement, 
66.11 	cannabis retailer, medical cannabis retailer, medical cannabis combination business, or 
66.12 	lower-potency hemp edible retailer must register with the city, town, or county in which 
66.13 	the retail establishment is located. A county may issue a registration in cases where a city 
66.14 	or town has provided consent for the county to issue the registration for the jurisdiction.
66.15 		Subd. 2.Registration fee. (a) A local unit of government may impose an initial retail 
66.16 	registration fee of $500 or up to half the amount of the applicable initial license fee under 
66.17 	section 342.11, whichever is less. The local unit of government may also impose a renewal 
66.18 	retail registration fee of $1,000 or up to half the amount of the applicable renewal license 
66.19 	fee under section 342.11, whichever is less. The initial registration fee shall include the fee 
66.20 	for initial registration and the first annual renewal. Any renewal fee imposed by the local 
66.21 	unit of government shall be charged at the time of the second renewal and each subsequent 
66.22 	annual renewal thereafter.
66.23 	(b) The local unit of government may not charge an application fee.
66.24 	(c) A cannabis business with a cannabis retailer license and a medical cannabis retailer 
66.25 	license for the same location may only be charged a single registration fee.
66.26 	(d) (c) Registration fees are nonrefundable.
66.27 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
66.28 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
66.29 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
66.30 	retailer, or lower-potency hemp edible retailer that:
66.31 	(1) has a valid license issued an application that has been approved by the office;
66.32 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
67.1 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
67.2 	compliance check that the local unit of government performs; and
67.3 	(4) if applicable, is current on all property taxes and assessments at the location where 
67.4 	the retail establishment is located.
67.5 	(b) Before issuing a retail registration, the local unit of government may conduct a 
67.6 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
67.7 	compliance with the any applicable operation requirements and the limits on the types of 
67.8 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
67.9 	products that may be sold local ordinance established pursuant to section 342.13.
67.10 	(c) A local unit of government shall renew the retail registration of a cannabis business 
67.11 	or hemp business when the office renews the license of the cannabis business or hemp 
67.12 	business.
67.13 	(d) A retail registration issued under this section may not be transferred.
67.14 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
67.15 	checks of every cannabis business and hemp business with a retail registration issued by 
67.16 	the local unit of government. The checks During a compliance check, a local unit of 
67.17 	government shall assess a business's compliance with age verification requirements, the
67.18 	and compliance with any applicable operation requirements, and the applicable limits on 
67.19 	the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
67.20 	hemp-derived consumer products being sold local ordinance established pursuant to section 
67.21 	342.13.
67.22 	(b) The A local unit of government must conduct unannounced age verification 
67.23 	compliance checks of every cannabis business and hemp business at least once each calendar 
67.24 	year. Age verification compliance checks must involve persons at least 17 years of age but 
67.25 	under the age of 21 who, with the prior written consent of a parent or guardian if the person 
67.26 	is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis 
67.27 	products, lower-potency hemp edibles, or hemp-derived consumer products under the direct 
67.28 	supervision of a law enforcement officer or an employee of the local unit of government.
67.29 	(c) Checks to ensure compliance with the applicable operation requirements and the 
67.30 	limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
67.31 	hemp-derived consumer products that may be sold must be performed at least once each 
67.32 	calendar year and may be performed by a law enforcement officer or an employee of the 
67.33 	local unit of government.
68.1 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
68.2 	a local unit of government determines that a cannabis business or hemp business with a 
68.3 	retail registration issued by the local unit of government is not operating in compliance with 
68.4 	the requirements of this chapter a local ordinance authorized under section 342.13 or that 
68.5 	the operation of the business poses an immediate threat to the health or safety of the public, 
68.6 	the local unit of government may suspend the retail registration of the cannabis business or 
68.7 	hemp business. The local unit of government must immediately notify the office of the 
68.8 	suspension and shall include a description of the grounds for the suspension.
68.9 	(b) The office shall review the retail registration suspension and may order reinstatement 
68.10 	of the retail registration or take any action described in section 342.19 or 342.21.
68.11 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
68.12 	the license and operating privilege of the cannabis business or hemp business for a longer 
68.13 	period or revokes the license.
68.14 	(d) The local unit of government may reinstate the retail registration if the local unit of 
68.15 	government determines that any violation has been cured. The local unit of government 
68.16 	must reinstate the retail registration if the office orders reinstatement.
68.17 	(e) No cannabis microbusiness with a retail operations endorsement, cannabis 
68.18 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
68.19 	retailer, medical cannabis combination business, or lower-potency hemp edible retailer may 
68.20 	make any sale to a customer or patient without a valid retail registration with a local unit 
68.21 	of government and a valid endorsement from the office. A local unit of government may 
68.22 	impose a civil penalty of up to $2,000 for each violation of this paragraph.

68.23 	Sec. 71. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended 
68.24 	to read:
68.25 		Subdivision 1.Individuals under 21 years of age. (a) A cannabis business may not 
68.26 	employ an individual under 21 years of age and may not contract with an individual under 
68.27 	21 years of age if the individual's scope of work involves the handling of cannabis plants, 
68.28 	cannabis flower, artificially derived cannabinoids, or cannabinoid products.
68.29 	(b) A cannabis business may not permit an individual under 21 years of age to enter the 
68.30 	business premises other than entry by a patient person enrolled in the registry program.
68.31 	(c) A cannabis business may not sell or give cannabis flower, cannabis products, 
68.32 	lower-potency hemp edibles, or hemp-derived consumer products to an individual under 
68.33 	21 years of age unless the individual is a patient; registered designated caregiver; or a parent, 
69.1 	legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical 
69.2 	cannabis flower or medical cannabinoid products enrolled in the patient registry program 
69.3 	and the cannabis business holds a medical cannabis retail endorsement.

69.4 	Sec. 72. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended 
69.5 	to read:
69.6 		Subd. 2.Use of cannabis flower and products within a licensed cannabis business. (a) 
69.7 	A cannabis business may not permit an individual who is not an employee to consume 
69.8 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
69.9 	products within its licensed premises unless the business is licensed to permit on-site 
69.10 	consumption.
69.11 	(b) Except as otherwise provided in this subdivision, a cannabis business may not permit 
69.12 	an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles, 
69.13 	or hemp-derived consumer products within its licensed premises or while the employee is 
69.14 	otherwise engaged in activities within the course and scope of employment.
69.15 	(c) A cannabis business may permit an employee to use medical cannabis flower and 
69.16 	medical cannabinoid products if that individual is a patient enrolled in the registry program 
69.17 	and consuming cannabis as prescribed.
69.18 	(d) For quality control, employees of a licensed cannabis business may sample cannabis 
69.19 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products. 
69.20 	Employees may not interact directly with customers for at least three hours after sampling 
69.21 	a product. Employees may not consume more than three samples in a single 24-hour period. 
69.22 	All samples must be recorded in the statewide monitoring system.

69.23 	Sec. 73. Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a 
69.24 	subdivision to read:
69.25 		Subd. 1a.Cannabis research. A cannabis researcher employed by or affiliated with 
69.26 	institutions of higher education that are regionally or nationally accredited may apply for a 
69.27 	cannabis microbusiness license to conduct cannabis crop research. A cannabis researcher 
69.28 	with a cannabis microbusiness license may perform activities identified in subdivision 1, 
69.29 	clauses (1) to (9) and (13). Cannabis grown for research purposes must not be offered for 
69.30 	sale or otherwise enter the stream of commerce.

70.1 	Sec. 74. Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended 
70.2 	to read:
70.3 		Subd. 2.Size limitations. (a) A cannabis microbusiness that cultivates cannabis at an 
70.4 	indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust 
70.5 	plant canopy limits upward or downward but not below 5,000 square feet to meet market 
70.6 	demand consistent with the goals identified in section 342.02, subdivision 1.
70.7 	(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate 
70.8 	up to one-half acre of mature, flowering plants unless the office increases that limit. The 
70.9 	office may increase the limit to no more than one acre if the office determines that expansion 
70.10 	is. The office may adjust size limits upward or downward but not below one-half acre to 
70.11 	meet market demand consistent with the goals identified in section 342.02, subdivision 1.
70.12 	(c) The office shall establish a limit on the manufacturing of cannabis products, 
70.13 	lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness 
70.14 	that manufactures such products may perform. The limit must be equivalent to the amount 
70.15 	of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square 
70.16 	feet in a year, but may be increased if the office expands the allowable area of cultivation 
70.17 	under paragraph (a).
70.18 	(d) A cannabis microbusiness with the appropriate endorsement may operate one retail 
70.19 	location.

70.20 	Sec. 75. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 1, is amended 
70.21 	to read:
70.22 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
70.23 	the specific license endorsement or endorsements, entitles the license holder to perform any 
70.24 	or all of the following within the limits established by this section:
70.25 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
70.26 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
70.27 	adult-use cannabis products;
70.28 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
70.29 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
70.30 	cannabinoid products;
70.31 	(3) (2) make cannabis concentrate;
71.1 	(4) (3) make hemp concentrate, including hemp concentrate with a delta-9 
71.2 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
71.3 	(5) (4) manufacture artificially derived cannabinoids;
71.4 	(6) (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
71.5 	hemp-derived consumer products for public consumption;
71.6 	(7) (6) manufacture and process medical cannabinoid products;
71.7 	(8) (7) purchase immature cannabis plants and seedlings and cannabis flower from a 
71.8 	cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a 
71.9 	cannabis wholesaler;
71.10 	(9) (8) purchase cannabis concentrate, hemp concentrate, and synthetically derived 
71.11 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
71.12 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
71.13 	lower-potency hemp edibles, or hemp-derived consumer products;
71.14 	(10) (9) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
71.15 	under chapter 18K;
71.16 	(11) (10) purchase hemp concentrate from an industrial hemp processor licensed under 
71.17 	chapter 18K;
71.18 	(12) (11) package and label adult-use cannabis flower, adult-use cannabis products, 
71.19 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
71.20 	(13) (12) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
71.21 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
71.22 	other products authorized by law to other cannabis businesses and to customers; and
71.23 	(14) (13) perform other actions approved by the office.

71.24 	Sec. 76. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended 
71.25 	to read:
71.26 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
71.27 	cannabis mezzobusiness license may also hold a cannabis event organizer license and a 
71.28 	medical cannabis retailer license.
71.29 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
71.30 	cannabis mezzobusiness license may own or operate any other cannabis business or hemp 
71.31 	business or hold more than one cannabis mezzobusiness license.
72.1 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
72.2 	a business may hold applies to every cooperative member or every director, manager, and 
72.3 	general partner of a cannabis business.

72.4 	Sec. 77. Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended 
72.5 	to read:
72.6 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
72.7 	cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis 
72.8 	cultivator license, medical cannabis producer license, license to grow industrial hemp, and 
72.9 	cannabis event organizer license.
72.10 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
72.11 	cannabis cultivator license may own or operate any other cannabis business or hemp business. 
72.12 	This prohibition does not prevent the transportation of cannabis flower from a cannabis 
72.13 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
72.14 	and located on the same premises.
72.15 	(c) The office by rule may limit the number of cannabis cultivator licenses a person, 
72.16 	cooperative, or business may hold.
72.17 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
72.18 	business may hold applies to every cooperative member or every director, manager, and 
72.19 	general partner of a cannabis business.

72.20 	Sec. 78. Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended 
72.21 	to read:
72.22 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
72.23 	cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis 
72.24 	cultivator license, a medical cannabis processor license, and a cannabis event organizer 
72.25 	license.
72.26 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
72.27 	cannabis manufacturer license may own or operate any other cannabis business or hemp 
72.28 	business. This prohibition does not prevent transportation of cannabis flower from a cannabis 
72.29 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
72.30 	and located on the same premises.
72.31 	(c) The office by rule may limit the number of cannabis manufacturer licenses that a 
72.32 	person or business may hold.
73.1 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
73.2 	a business may hold applies to every cooperative member or every director, manager, and 
73.3 	general partner of a cannabis business.

73.4 	Sec. 79. Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended 
73.5 	to read:
73.6 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
73.7 	cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis 
73.8 	retailer license, and a cannabis event organizer license.
73.9 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
73.10 	cannabis retailer license may own or operate any other cannabis business or hemp business.
73.11 	(c) No person, cooperative, or business may hold a license to own or operate more than 
73.12 	one cannabis retail business in one city and three retail businesses in one county.
73.13 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
73.14 	cooperative, or business may hold.
73.15 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
73.16 	business may hold applies to every cooperative member or every director, manager, and 
73.17 	general partner of a cannabis business.

73.18 	Sec. 80. Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended 
73.19 	to read:
73.20 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
73.21 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
73.22 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
73.23 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
73.24 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
73.25 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers, 
73.26 	medical cannabis processors, and industrial hemp growers to cannabis microbusinesses, 
73.27 	cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
73.28 	wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis 
73.29 	processors, medical cannabis retailers, and medical cannabis combination businesses and 
73.30 	perform other actions approved by the office.

74.1 	Sec. 81. Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended 
74.2 	to read:
74.3 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
74.4 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
74.5 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
74.6 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
74.7 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
74.8 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
74.9 	cultivators, medical cannabis processors, medical cannabis combination businesses, and 
74.10 	industrial hemp growers.

74.11 	Sec. 82. Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended 
74.12 	to read:
74.13 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
74.14 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency 
74.15 	hemp edible retailers, including the cannabis event organizer, may be authorized to sell 
74.16 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
74.17 	hemp edibles, and hemp-derived consumer products to customers at a cannabis event.
74.18 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
74.19 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
74.20 	take place in a retail area as designated in the premises diagram.
74.21 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
74.22 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
74.23 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
74.24 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
74.25 	products to an individual under 21 years of age.
74.26 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
74.27 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
74.28 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
74.29 	products must be stored in a sample jar or display case and be accompanied by a label or 
74.30 	notice containing the information required to be affixed to the packaging or container 
74.31 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
74.32 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
74.33 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
75.1 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
75.2 	cannabis flower or adult-use cannabis product before purchase.
75.3 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
75.4 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
75.5 	and hemp-derived consumer products for sale at a cannabis event.
75.6 	(g) Authorized retailers may not:
75.7 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
75.8 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
75.9 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
75.10 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
75.11 	is legally permitted to possess;
75.12 	(3) sell medical cannabis flower or medical cannabinoid products;
75.13 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
75.14 	edibles, or hemp-derived consumer products; or
75.15 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
75.16 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
75.17 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
75.18 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
75.19 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
75.20 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
75.21 	locked container that is not accessible to the public. Such items being stored at a cannabis 
75.22 	event shall not be left unattended.
75.23 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
75.24 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
75.25 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
75.26 	the testing, packaging, and labeling of those items.
75.27 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
75.28 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
75.29 	system.

76.1 	Sec. 83. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 1, is amended 
76.2 	to read:
76.3 		Subdivision 1.Authorized actions. A cannabis delivery service license entitles the 
76.4 	license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles, 
76.5 	and hemp-derived consumer products from licensed cannabis microbusinesses with a retail 
76.6 	endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, 
76.7 	medical cannabis retailers, and medical cannabis combination businesses; transport and 
76.8 	deliver cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived 
76.9 	consumable products to customers; and perform other actions approved by the office.

76.10 	Sec. 84. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended 
76.11 	to read:
76.12 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
76.13 	cannabis delivery service license may also hold a cannabis retailer license, a cannabis 
76.14 	wholesaler license, a cannabis transporter license, and a cannabis event organizer license, 
76.15 	and a medical cannabis retailer license subject to the ownership limitations that apply to 
76.16 	those licenses.
76.17 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
76.18 	cannabis delivery service license may own or operate any other cannabis business or hemp 
76.19 	business.
76.20 	(c) The office by rule may limit the number of cannabis delivery service licenses that a 
76.21 	person or business may hold.
76.22 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
76.23 	a business may hold applies to every cooperative member or every director, manager, and 
76.24 	general partner of a cannabis business.

76.25 	Sec. 85. [342.465] LOWER-POTENCY HEMP EDIBLES; PROHIBITED CONDUCT.
76.26 	No person may sell, give, furnish, or in any way procure for another person lower-potency 
76.27 	hemp edibles for the use of an obviously impaired person.

76.28 	Sec. 86. Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:
76.29 	342.51 MEDICAL CANNABIS RETAILERS RETAIL ENDORSEMENT.
76.30 		Subdivision 1.Authorized actions. (a) The office must issue a medical cannabis retail 
76.31 	endorsement to a cannabis business, if the business:
77.1 	(1) submits a medical cannabis retail endorsement application to the office;
77.2 	(2) has at least one employee who earned a medical cannabis consultant certificate issued 
77.3 	by the office and has completed the required training or has at least one employee who is 
77.4 	a licensed pharmacist under chapter 151; and
77.5 	(3) otherwise meets all applicable requirements established by the office.
77.6 	(b) A medical cannabis retailer license retail endorsement entitles the license holder to 
77.7 	purchase medical cannabis flower and medical cannabinoid products from medical cannabis 
77.8 	cultivators and medical cannabis processors and sell or distribute medical cannabis flower 
77.9 	and medical cannabinoid products to any person authorized to receive medical cannabis 
77.10 	flower or medical cannabinoid products. sell or distribute the following products to any 
77.11 	person enrolled in the medical cannabis patient registry under section 342.52:
77.12 	(1) cannabis plants, cannabis flower, cannabis products, artificially derived cannabinoids, 
77.13 	lower-potency hemp edibles, and hemp-derived consumer products that are a product 
77.14 	category approved by the office and that comply with this chapter and rules adopted pursuant 
77.15 	to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis 
77.16 	flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, 
77.17 	and hemp-derived consumer products; and
77.18 	(2) associated paraphernalia.
77.19 	(b) (c) A medical cannabis retailer license retail endorsement holder must verify that all 
77.20 	medical cannabis flower and medical cannabinoid products under paragraph (b), clause (1), 
77.21 	have passed safety, potency, and consistency testing at a cannabis testing facility approved 
77.22 	by the office for the testing of medical cannabis flower and medical cannabinoid products 
77.23 	under paragraph (b), clause (1), before the medical cannabis retailer business may distribute 
77.24 	the medical cannabis flower or medical cannabinoid product products to any person 
77.25 	authorized to receive medical cannabis flower or medical cannabinoid products enrolled in 
77.26 	the medical cannabis patient registry program under section 342.52.
77.27 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
77.28 	or medical cannabinoid products, a medical cannabis retailer licensee products listed in 
77.29 	subdivision 1, paragraph (b), to a person enrolled in the patient registry program, an employee 
77.30 	with a valid medical cannabis consultant certificate issued by the office or a licensed 
77.31 	pharmacist under chapter 151 must:
77.32 	(1) review and confirm the patient's enrollment in the registry verification program;
78.1 	(2) verify that the person requesting the distribution of medical cannabis flower or 
78.2 	medical cannabinoid products listed under subdivision 1, paragraph (b), is the patient, the 
78.3 	patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
78.4 	using the procedures specified in section 152.11, subdivision 2d established by the office;
78.5 	(3) ensure that a pharmacist employee of the medical cannabis retailer has consulted 
78.6 	with the patient if required according to subdivision 3; and
78.7 	(3) provide consultation to the patient to determine the proper type of product, dosage, 
78.8 	and paraphernalia for the patient if required under subdivision 3;
78.9 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
78.10 	product that includes recommended dosage requirements and other information as required 
78.11 	by rules adopted by the office.; and
78.12 	(5) provide the patient with any other information required by the office.
78.13 	(b) A medical cannabis retailer retail endorsement holder may not deliver medical 
78.14 	cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph (b), to 
78.15 	a person enrolled in the patient registry program unless the medical cannabis retailer retail 
78.16 	endorsement holder also holds a cannabis delivery service license. The delivery of medical 
78.17 	cannabis flower and medical cannabinoid products are a product listed in subdivision 1, 
78.18 	paragraph (b), is subject to the provisions of section 342.42.
78.19 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
78.20 	cannabinoid products. (a) A cannabis worker who is employed by a medical cannabis 
78.21 	retailer and retail endorsement holder who is licensed as a pharmacist pursuant to chapter 
78.22 	151shall be or certified as a medical cannabis consultant by the office is the only person 
78.23 	who may give final approval for the distribution of medical cannabis flower and medical 
78.24 	cannabinoid products listed in subdivision 1, paragraph (b). Prior to the distribution of 
78.25 	medical cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph 
78.26 	(b), a pharmacist or certified medical cannabis consultant employed by the a business with 
78.27 	a medical cannabis retailer retail endorsement must consult with the patient to determine 
78.28 	the proper type of medical cannabis flower, medical cannabinoid product, or medical cannabis
78.29 	proper type of paraphernalia, and proper dosage for the patient after reviewing the range of 
78.30 	chemical compositions of medical cannabis flower or medical cannabinoid the product.
78.31 	intended for distribution:
78.32 	(1) if the patient is purchasing the product for the first time;
79.1 	(2) if the patient purchases a product that the patient must administer using a different 
79.2 	method than the patient's previous method of administration;
79.3 	(3) if the patient purchases a product with a cannabinoid concentration of at least double 
79.4 	the patient's prior dosage; or
79.5 	(4) upon the request of the patient.
79.6 	(b) For purposes of this subdivision, a consultation may be conducted remotely by secure 
79.7 	videoconference, telephone, or other remote means, as long as:
79.8 	(1) the pharmacist or consultant engaging in the consultation is able to confirm the 
79.9 	identity of the patient; and
79.10 	(2) the consultation adheres to patient privacy requirements that apply to health care 
79.11 	services delivered through telemedicine.
79.12 	(b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the 
79.13 	distribution of medical cannabis flower or medical cannabinoid products when a medical 
79.14 	cannabis retailer is distributing medical cannabis flower or medical cannabinoid products 
79.15 	to a patient according to a patient-specific dosage plan established with that medical cannabis 
79.16 	retailer and is not modifying the dosage or product being distributed under that plan. Medical 
79.17 	cannabis flower or medical cannabinoid products distributed under this paragraph must be 
79.18 	distributed by a pharmacy technician employed by the medical cannabis retailer.
79.19 		Subd. 4.90-day supply. A medical cannabis retailer shall not distribute more than a 
79.20 	90-day supply of medical cannabis flower or medical cannabinoid products to a patient, 
79.21 	registered designated caregiver, or parent, legal guardian, or spouse of a patient according 
79.22 	to the dosages established for the individual patient.
79.23 		Subd. 5.Distribution to recipient in a motor vehicle. A medical cannabis retailer retail 
79.24 	endorsement holder may distribute medical cannabis flower and medical cannabinoid 
79.25 	products a product listed in subdivision 1, paragraph (b), to a patient, registered designated 
79.26 	caregiver, or parent, legal guardian, or spouse of a patient person enrolled in the patient 
79.27 	registry program who is at a dispensary location but remains in a motor vehicle, provided 
79.28 	that:
79.29 	(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid 
79.30 	products a product listed in subdivision 1, paragraph (b), in a designated zone that is as 
79.31 	close as feasible to the front door of the facility;
79.32 	(2) the medical cannabis retailer retail endorsement holder ensures that the receipt of 
79.33 	payment and distribution of medical cannabis flower and medical cannabinoid products a 
80.1 	product listed in subdivision 1, paragraph (b), are visually recorded by a closed-circuit 
80.2 	television surveillance camera and provides any other necessary security safeguards;
80.3 	(3) the medical cannabis retailer retail endorsement holder does not store medical cannabis 
80.4 	flower or medical cannabinoid products a product listed in subdivision 1, paragraph (b),
80.5 	outside a restricted access area and staff transport medical cannabis flower and medical 
80.6 	cannabinoid products the product from a restricted access area to the designated zone for 
80.7 	distribution only after confirming that the patient, designated caregiver, or parent, guardian, 
80.8 	or spouse person enrolled in the patient registry program has arrived in the designated zone;
80.9 	(4) the payment for and distribution of medical cannabis flower and medical cannabinoid 
80.10 	products a product listed in subdivision 1, paragraph (b), take place only after a pharmacist 
80.11 	consultation takes place, if required under subdivision 3 meeting the requirements in 
80.12 	subdivision 2;
80.13 	(5) immediately following the distribution of medical cannabis flower or medical 
80.14 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff enter record the 
80.15 	transaction in the statewide monitoring system; and
80.16 	(6) immediately following the distribution of medical cannabis flower and medical 
80.17 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff take the payment 
80.18 	received into the facility.

80.19 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
80.20 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
80.21 	is later.

80.22 	Sec. 87. Minnesota Statutes 2023 Supplement, section 342.515, is amended to read:
80.23 	342.515 MEDICAL CANNABIS COMBINATION BUSINESSES.
80.24 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
80.25 	medical cannabis combination business license is prohibited from owning or operating any 
80.26 	other cannabis business or hemp business or holding an active registration agreement under 
80.27 	section 152.25, subdivision 1.
80.28 	(b) A person or business may hold only one medical cannabis combination business 
80.29 	license.
80.30 	(c) A medical cannabis combination business license entitles the license holder to perform 
80.31 	any or all of the following within the limits established by this section:
81.1 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
81.2 	adult-use cannabis flower and medical cannabis flower from a mature plant;
81.3 	(2) make cannabis concentrate;
81.4 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
81.5 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
81.6 	(4) manufacture artificially derived cannabinoids;
81.7 	(5) manufacture medical cannabinoid products;
81.8 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
81.9 	hemp-derived consumer products for public consumption;
81.10 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
81.11 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
81.12 	a medical cannabis cultivator, or another medical cannabis combination business;
81.13 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
81.14 	under chapter 18K;
81.15 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
81.16 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
81.17 	cannabis wholesaler, a medical cannabis processor, or another medical cannabis combination 
81.18 	business;
81.19 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
81.20 	18K;
81.21 	(11) package and label medical cannabis flower and medical cannabinoid products for 
81.22 	sale to medical cannabis processors, medical cannabis retailers, other medical cannabis 
81.23 	combination businesses, and patients enrolled in the registry program, registered designated 
81.24 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
81.25 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
81.26 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
81.27 	(13) sell medical cannabis flower and medical cannabinoid products to patients enrolled 
81.28 	in the registry program, registered designated caregivers, and parents, legal guardians, and 
81.29 	spouses of an enrolled patient;
81.30 	(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
81.31 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
81.32 	other products authorized by law to other cannabis businesses and to customers; and
82.1 	(15) perform other actions approved by the office.
82.2 		Subd. 2.Cultivation; size limitations. (a) A medical cannabis combination business 
82.3 	may cultivate cannabis to be sold as medical cannabis flower or used in medical cannabinoid 
82.4 	products in an area of up to 60,000 square feet of plant canopy subject to the limits on 
82.5 	adult-use cannabis cultivation in paragraph (c).
82.6 	(b) A medical cannabis combination business may cultivate cannabis to be sold as 
82.7 	adult-use cannabis flower or used in adult-use cannabis products in an area authorized by 
82.8 	the office as described in paragraph (c).
82.9 	(c) The office shall authorize a medical cannabis combination business to cultivate 
82.10 	cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half 
82.11 	of the area the business used to cultivate cannabis sold in the medical market in the preceding 
82.12 	year. The office shall establish an annual verification and authorization procedure. The 
82.13 	office may increase the area of plant canopy in which a medical cannabis combination 
82.14 	business is authorized to cultivate cannabis for sale in the adult-use market between 
82.15 	authorization periods if the business demonstrates a significant increase in the sale of medical 
82.16 	cannabis and medical cannabis products.
82.17 		Subd. 3.Manufacturing; size limitations. The office may establish limits on cannabis 
82.18 	manufacturing that are consistent with the area of plant canopy a business is authorized to 
82.19 	cultivate.
82.20 		Subd. 4.Retail locations. A medical cannabis combination business may operate up to 
82.21 	one retail location in each congressional district. A medical cannabis combination business 
82.22 	must offer medical cannabis flower, medical cannabinoid products, or both at every retail 
82.23 	location. Each retail location of a medical cannabis combination business must continuously 
82.24 	make cannabis flower or cannabinoid products available to patients enrolled in the registry 
82.25 	program, registered designated caregivers, and parents, legal guardians, and spouses of an 
82.26 	enrolled patient.
82.27 		Subd. 5.Failure to participate; suspension or revocation of license. The office may 
82.28 	suspend or revoke a medical cannabis combination business license if the office determines 
82.29 	that the business is no longer actively participating in the medical cannabis market. The 
82.30 	office may, by rule, establish minimum requirements related to cannabis cultivation, 
82.31 	manufacturing of medical cannabinoid products, retail sales of medical cannabis flower and 
82.32 	medical cannabinoid products, and other relevant criteria to demonstrate active participation 
82.33 	in the medical cannabis market.
83.1 		Subd. 6.Operations. A medical cannabis combination business must comply with the 
83.2 	relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.

83.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

83.4 	Sec. 88. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended 
83.5 	to read:
83.6 		Subdivision 1.Administration. The Division of Medical Cannabis office must administer 
83.7 	the medical cannabis patient registry program.

83.8 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
83.9 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
83.10 	is later.

83.11 	Sec. 89. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended 
83.12 	to read:
83.13 		Subd. 2.Application procedure for patients. (a) A patient seeking to enroll in the 
83.14 	registry program must submit to the Division of Medical Cannabis office an application 
83.15 	established by the Division of Medical Cannabis office and a copy of the certification 
83.16 	specified in paragraph (b) or, if the patient is a veteran who receives care from the United 
83.17 	States Department of Veterans Affairs, the information required pursuant to subdivision 3. 
83.18 	The patient must provide at least the following information in the application:
83.19 	(1) the patient's name, mailing address, and date of birth;
83.20 	(2) the name, mailing address, and telephone number of the patient's health care 
83.21 	practitioner;
83.22 	(3) the name, mailing address, and date of birth of the patient's registered designated 
83.23 	caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, 
83.24 	or spouse will be acting as the patient's caregiver;
83.25 	(4) a disclosure signed by the patient that includes:
83.26 	(i) a statement that, notwithstanding any law to the contrary, the office of Cannabis 
83.27 	Management, the Division of Medical Cannabis, or an employee of the office of Cannabis 
83.28 	Management or Division of Medical Cannabis may not be held civilly or criminally liable 
83.29 	for any injury, loss of property, personal injury, or death caused by an act or omission while 
83.30 	acting within the employee's scope of office or employment under this section; and
84.1 	(ii) the patient's acknowledgment that enrollment in the registry program is conditional 
84.2 	on the patient's agreement to meet all other requirements of this section; and
84.3 	(5) all other information required by the Division of Medical Cannabis office.
84.4 	(b) As part of the application under this subdivision, a patient must submit a copy of a 
84.5 	certification from the patient's health care practitioner that is dated within 90 days prior to 
84.6 	the submission of the application and that certifies that the patient has been diagnosed with 
84.7 	a qualifying medical condition.
84.8 	(c) A patient's health care practitioner may submit a statement to the Division of Medical 
84.9 	Cannabis office declaring that the patient is no longer diagnosed with a qualifying medical 
84.10 	condition. Within 30 days after receipt of a statement from a patient's health care practitioner, 
84.11 	the Division of Medical Cannabis office must provide written notice to a patient stating that 
84.12 	the patient's enrollment in the registry program will be revoked in 30 days unless the patient 
84.13 	submits a certification from a health care practitioner that the patient is currently diagnosed 
84.14 	with a qualifying medical condition or, if the patient is a veteran, the patient submits 
84.15 	confirmation that the patient is currently diagnosed with a qualifying medical condition in 
84.16 	a form and manner consistent with the information required for an application made pursuant 
84.17 	to subdivision 3. If the Division of Medical Cannabis office revokes a patient's enrollment 
84.18 	in the registry program pursuant to this paragraph, the division must provide notice to the 
84.19 	patient and to the patient's health care practitioner.

84.20 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
84.21 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
84.22 	is later.

84.23 	Sec. 90. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended 
84.24 	to read:
84.25 		Subd. 3.Application procedure for veterans. (a) The Division of Medical Cannabis
84.26 	office shall establish an alternative certification procedure for veterans who receive care 
84.27 	from the United States Department of Veterans Affairs to confirm that the veteran has been 
84.28 	diagnosed with a qualifying medical condition.
84.29 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
84.30 	submit to the Division of Medical Cannabis office a copy of the patient's veteran health 
84.31 	identification card issued by the United States Department of Veterans Affairs and an 
84.32 	application established by the Division of Medical Cannabis that includes the information 
84.33 	identified in subdivision 2, paragraph (a), and the additional information required by the 
85.1 	Division of Medical Cannabis office to certify that the patient has been diagnosed with a 
85.2 	qualifying medical condition.

85.3 	EFFECTIVE DATE. This section is effective July 1, 2024.

85.4 	Sec. 91. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended 
85.5 	to read:
85.6 		Subd. 4.Enrollment; denial of enrollment; revocation. (a) Within 30 days after the 
85.7 	receipt of an application and certification or other documentation of a diagnosis with a 
85.8 	qualifying medical condition, the Division of Medical Cannabis office must approve or 
85.9 	deny a patient's enrollment in the registry program. If the Division of Medical Cannabis
85.10 	office approves a patient's enrollment in the registry program, the office must provide notice 
85.11 	to the patient and to the patient's health care practitioner.
85.12 	(b) The office may deny a patient's enrollment in the registry program must only be 
85.13 	denied only if the patient:
85.14 	(1) does not submit a certification from a health care practitioner or, if the patient is a 
85.15 	veteran, the documentation required under subdivision 3 that the patient has been diagnosed 
85.16 	with a qualifying medical condition;
85.17 	(2) has not signed the disclosure required in subdivision 2;
85.18 	(3) does not provide the information required by the Division of Medical Cannabis
85.19 	office;
85.20 	(4) provided false information on the application; or
85.21 	(5) at the time of application, is also enrolled in a federally approved clinical trial for 
85.22 	the treatment of a qualifying medical condition with medical cannabis.
85.23 	(c) If the Division of Medical Cannabis office denies a patient's enrollment in the registry 
85.24 	program, the Division of Medical Cannabis office must provide written notice to a patient 
85.25 	of all reasons for denying enrollment. Denial of enrollment in the registry program is 
85.26 	considered a final decision of the office and is subject to judicial review under chapter 14.
85.27 	(d) The office may revoke a patient's enrollment in the registry program may be revoked
85.28 	only:
85.29 	(1) pursuant to subdivision 2, paragraph (c);
85.30 	(2) upon the death of the patient;
86.1 	(3) if the patient's certifying health care practitioner has filed a declaration under 
86.2 	subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the 
86.3 	patient does not submit another certification within 30 days;
86.4 	(4) if the patient does not comply with subdivision 6; or
86.5 	(5) if the patient intentionally sells or diverts medical cannabis flower or medical
86.6 	cannabinoid products in violation of this chapter.
86.7 	(e) If the office has revoked a patient's enrollment in the registry program has been 
86.8 	revoked due to a violation of subdivision 6, the patient may apply for enrollment 12 months 
86.9 	after the date on which the patient's enrollment was revoked. The office must process such 
86.10 	an application in accordance with this subdivision.

86.11 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
86.12 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
86.13 	is later.

86.14 	Sec. 92. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended 
86.15 	to read:
86.16 		Subd. 5.Registry verification. When a patient is enrolled in the registry program, the 
86.17 	Division of Medical Cannabis office must assign the patient a patient registry number and 
86.18 	must issue the patient and the patient's registered designated caregiver, parent, legal guardian, 
86.19 	or spouse, if applicable, a registry verification. The Division of Medical Cannabis office
86.20 	must also make the registry verification available to medical cannabis retailers businesses 
86.21 	with a medical cannabis retail endorsement. The registry verification must include:
86.22 	(1) the patient's name and date of birth;
86.23 	(2) the patient registry number assigned to the patient; and
86.24 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
86.25 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
86.26 	spouse will act as a caregiver.

86.27 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
86.28 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
86.29 	is later.

87.1 	Sec. 93. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended 
87.2 	to read:
87.3 		Subd. 9.Registered designated caregiver. (a) The Division of Medical Cannabis office
87.4 	must register a designated caregiver for a patient if the patient requires assistance in 
87.5 	administering medical cannabis flower or medical cannabinoid products or in obtaining 
87.6 	medical cannabis flower, medical cannabinoid products, or medical cannabis paraphernalia 
87.7 	from a medical cannabis retailer business with a medical cannabis retail endorsement under 
87.8 	section 342.51.
87.9 	(b) In order to serve as a designated caregiver, a person must:
87.10 	(1) be at least 18 years of age;
87.11 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
87.12 	products purchased under section 342.51 for purposes of assisting the patient; and
87.13 	(3) agree that if the application is approved, the person will not serve as a registered 
87.14 	designated caregiver for more than six registered patients at one time. Patients who reside 
87.15 	in the same residence count as one patient.
87.16 	(c) The office shall conduct a criminal background check on the designated caregiver 
87.17 	prior to registration to ensure that the person does not have a conviction for a disqualifying 
87.18 	felony offense. Any cost of the background check shall be paid by the person seeking 
87.19 	registration as a designated caregiver. A designated caregiver must have the criminal 
87.20 	background check renewed every two years.
87.21 	(d) (c) Nothing in this section shall be construed to prevent a registered designated 
87.22 	caregiver from being enrolled in the registry program as a patient and possessing and 
87.23 	administering medical cannabis flower or medical cannabinoid products as a patient.

87.24 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
87.25 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
87.26 	is later.

87.27 	Sec. 94. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended 
87.28 	to read:
87.29 		Subd. 11.Notice of change of name or address. Patients and registered designated 
87.30 	caregivers must notify the Division of Medical Cannabis office of any address or name 
87.31 	change within 30 days of the change having occurred. A patient or registered designated 
87.32 	caregiver is subject to a $100 fine for failure to notify the office of the change.

88.1 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
88.2 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
88.3 	is later.

88.4 	Sec. 95. Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:
88.5 	342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; REGISTRY 
88.6 	PROGRAM ADDING OR MODIFYING QUALIFYING MEDICAL CONDITIONS.
88.7 	The office may add an allowable form of medical cannabinoid product, and may add or 
88.8 	modify a qualifying medical condition upon its the office's own initiative, upon a petition 
88.9 	from a member of the public or from the Cannabis Advisory Council, or as directed by law. 
88.10 	The office must evaluate all petitions and must make the addition or modification if the 
88.11 	office determines that the addition or modification is warranted by the best available evidence 
88.12 	and research. If the office wishes to add an allowable form or add or modify a qualifying 
88.13 	medical condition, the office must notify the chairs and ranking minority members of the 
88.14 	legislative committees and divisions with jurisdiction over health finance and policy by 
88.15 	January 15 of the year in which the change becomes effective. In this notification, the office 
88.16 	must specify the proposed addition or modification, the reasons for the addition or 
88.17 	modification, any written comments received by the office from the public about the addition 
88.18 	or modification, and any guidance received from the Cannabis Advisory Council. An addition 
88.19 	or modification by the office under this subdivision becomes effective on August 1 of that 
88.20 	year unless the legislature by law provides otherwise.

88.21 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
88.22 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
88.23 	is later.

88.24 	Sec. 96. Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:
88.25 	342.54 DUTIES OF DIVISION OF MEDICAL CANNABIS OFFICE OF 
88.26 	CANNABIS MANAGEMENT; MEDICAL CANNABIS PATIENT REGISTRY 
88.27 	PROGRAM.
88.28 		Subdivision 1.Duties related to health care practitioners. The Division of Medical 
88.29 	Cannabis office must:
88.30 	(1) provide notice of the registry program to health care practitioners in the state;
88.31 	(2) allow health care practitioners to participate in the registry program if they request 
88.32 	to participate and meet the program's requirements;
89.1 	(3) provide explanatory information and assistance to health care practitioners to 
89.2 	understand the nature of the therapeutic use of medical cannabis flower and medical
89.3 	cannabinoid products within program requirements;
89.4 	(4) make available to participating health care practitioners a certification form in which 
89.5 	a health care practitioner certifies that a patient has a qualifying medical condition; and
89.6 	(5) supervise the participation of health care practitioners in the registry reporting system 
89.7 	in which health care practitioners report patient treatment and health records information 
89.8 	to the office in a manner that ensures stringent security and record keeping requirements 
89.9 	and that prevents the unauthorized release of private data on individuals as defined in section 
89.10 	13.02.
89.11 		Subd. 2.Duties related to the medical registry program. The Division of Medical 
89.12 	Cannabis office must:
89.13 	(1) administer the registry program according to section 342.52;
89.14 	(2) provide information to patients enrolled in the registry program on the existence of 
89.15 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
89.16 	with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 
89.17 	in the registry program;
89.18 	(3) maintain safety criteria with which patients must comply as a condition of participation 
89.19 	in the registry program to prevent patients from undertaking any task under the influence 
89.20 	of medical cannabis flower or medical cannabinoid products that would constitute negligence 
89.21 	or professional malpractice;
89.22 	(4) review and publicly report on existing medical and scientific literature regarding the 
89.23 	range of recommended dosages for each qualifying medical condition, the range of chemical 
89.24 	compositions of medical cannabis flower and medical cannabinoid products that will likely 
89.25 	be medically beneficial for each qualifying medical condition, and any risks of noncannabis 
89.26 	drug interactions. This information must be updated by December 1 of each yearevery three 
89.27 	years. The office may consult with an independent laboratory under contract with the office 
89.28 	or other experts in reporting and updating this information; and
89.29 	(5) annually consult with cannabis businesses about medical cannabis that the businesses 
89.30 	cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis
89.31 	office website a list of the medical cannabis flower and medical cannabinoid products offered 
89.32 	for sale by each medical cannabis retailer.
90.1 		Subd. 3.Research. (a) The Division of Medical Cannabis office must conduct or contract 
90.2 	with a third party to conduct research and studies using data from health records submitted 
90.3 	to the registry program under section 342.55, subdivision 2, and data submitted to the registry 
90.4 	program under section 342.52, subdivisions 2 and 3. If the division office contracts with a 
90.5 	third party for research and studies, the third party must provide the division office with 
90.6 	access to all research and study results. The division office must submit reports on 
90.7 	intermediate or final research results to the legislature and major scientific journals. All 
90.8 	data used by the division office or a third party under this subdivision must be used or 
90.9 	reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed 
90.10 	publication of research or in the creation of summary data, as defined in section 13.02, 
90.11 	subdivision 19.
90.12 	(b) The Division of Medical Cannabis office may submit medical research based on the 
90.13 	data collected under sections 342.55, subdivision 2, and data collected through the statewide 
90.14 	monitoring system to any federal agency with regulatory or enforcement authority over 
90.15 	medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness 
90.16 	of medical cannabis flower or medical cannabinoid products for treating or alleviating the 
90.17 	symptoms of a qualifying medical condition.

90.18 	EFFECTIVE DATE. This section is effective July 1, 2024.

90.19 	Sec. 97. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended 
90.20 	to read:
90.21 		Subdivision 1.Health care practitioner duties before patient enrollment. Before a 
90.22 	patient's enrollment in the registry program, a health care practitioner must:
90.23 	(1) determine, in the health care practitioner's medical judgment, whether a patient has 
90.24 	a qualifying medical condition and, if so determined, provide the patient with a certification 
90.25 	of that diagnosis;
90.26 	(2) advise patients, registered designated caregivers, and parents, legal guardians, and 
90.27 	spouses acting as caregivers of any nonprofit patient support groups or organizations;
90.28 	(3) provide to patients explanatory information from the Division of Medical Cannabis
90.29 	office, including information about the experimental nature of the therapeutic use of medical
90.30 	cannabis flower and medical cannabinoid products; the possible risks, benefits, and side 
90.31 	effects of the proposed treatment; and the application and other materials from the office;
90.32 	(4) provide to patients a Tennessen warning as required under section 13.04, subdivision 
90.33 	2; and
91.1 	(5) agree to continue treatment of the patient's qualifying medical condition and to report 
91.2 	findings to the Division of Medical Cannabis office.

91.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
91.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
91.5 	is later.

91.6 	Sec. 98. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended 
91.7 	to read:
91.8 		Subd. 2.Duties upon patient's enrollment in registry program. Upon receiving 
91.9 	notification from the Division of Medical Cannabis office of the patient's enrollment in the 
91.10 	registry program, a health care practitioner must:
91.11 	(1) participate in the patient registry reporting system under the guidance and supervision 
91.12 	of the Division of Medical Cannabis office;
91.13 	(2) report to the Division of Medical Cannabis office patient health records throughout 
91.14 	the patient's ongoing treatment in a manner determined by the office and in accordance with 
91.15 	subdivision 4;
91.16 	(3) determine on a yearly basisevery three years if the patient continues to have a 
91.17 	qualifying medical condition and, if so, issue the patient a new certification of that diagnosis. 
91.18 	The patient assessment conducted under this clause may be conducted via telehealth, as 
91.19 	defined in section 62A.673, subdivision 2; and
91.20 	(4) otherwise comply with requirements established by the office of Cannabis 
91.21 	Management and the Division of Medical Cannabis.

91.22 	EFFECTIVE DATE. This section is effective July 1, 2024.

91.23 	Sec. 99. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended 
91.24 	to read:
91.25 		Subdivision 1.Limitations on consumption; locations of consumption. (a) Nothing 
91.26 	in sections 342.47 342.51 to 342.60 permits any person to engage in, and does not prevent 
91.27 	the imposition of any civil, criminal, or other penalties for:
91.28 	(1) undertaking a task under the influence of medical cannabis flower or medical
91.29 	cannabinoid products that would constitute negligence or professional malpractice;
91.30 	(2) possessing or consuming medical cannabis flower or medical cannabinoid products:
91.31 	(i) on a school bus or van;
92.1 	(ii) in a correctional facility;
92.2 	(iii) in a state-operated treatment program, including the Minnesota sex offender program; 
92.3 	or
92.4 	(iv) on the grounds of a child care facility or family or group family day care program;
92.5 	(3) vaporizing or smoking medical cannabis:
92.6 	(i) on any form of public transportation;
92.7 	(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would 
92.8 	be inhaled by a minor; or
92.9 	(iii) in any public place, including any indoor or outdoor area used by or open to the 
92.10 	general public or a place of employment, as defined in section 144.413, subdivision 1b; and
92.11 	(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft, 
92.12 	train, or motorboat or working on transportation property, equipment, or facilities while 
92.13 	under the influence of medical cannabis flower or a medical cannabinoid product.
92.14 	(b) Except for the use of medical cannabis flower or medical cannabinoid products by 
92.15 	a patient enrolled in the patient registry program under section 342.52, the vaporizing or 
92.16 	smoking of cannabis flower, cannabis products, artificially derived cannabinoids, or 
92.17 	hemp-derived consumer products is prohibited in a multifamily housing building, including 
92.18 	balconies and patios appurtenant thereto. A violation of this paragraph is punishable through 
92.19 	a civil administrative fine in an amount of $250.

92.20 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
92.21 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
92.22 	is later.

92.23 	Sec. 100. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended 
92.24 	to read:
92.25 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
92.26 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
92.27 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
92.28 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
92.29 	144; and other health care facilities licensed by the commissioner of health or the 
92.30 	commissioner of human services may adopt reasonable restrictions on the use of medical
92.31 	cannabis flower or medical cannabinoid products by a patient enrolled in the registry program 
92.32 	who resides at or is actively receiving treatment or care at the facility. The restrictions may 
93.1 	include a provision that the facility must not store or maintain a patient's supply of medical
93.2 	cannabis flower or medical cannabinoid products on behalf of the patient; that a patient 
93.3 	store the patient's supply of medical cannabis flower or medicinal cannabinoid products in 
93.4 	a locked container accessible only to the patient, the patient's designated caregiver, or the 
93.5 	patient's parent, legal guardian, or spouse; that the facility is not responsible for providing 
93.6 	medical cannabis for patients; and that medical cannabis flower or medical cannabinoid 
93.7 	products are used only in a location specified by the facility or provider. Nothing in this 
93.8 	subdivision requires facilities and providers listed in this subdivision to adopt such 
93.9 	restrictions.
93.10 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
93.11 	access to or use of medical cannabis flower or medical cannabinoid products to the extent 
93.12 	that such use is authorized under sections 342.47 342.51 to 342.59. No facility or provider 
93.13 	listed in this subdivision may prohibit a patient access to or use of medical cannabis flower 
93.14 	or medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug 
93.15 	pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency, 
93.16 	the United States Department of Justice, or the federal Centers for Medicare and Medicaid 
93.17 	Services takes one of the following actions, a facility or provider may suspend compliance 
93.18 	with this paragraph until the regulatory agency, the United States Department of Justice, or 
93.19 	the federal Centers for Medicare and Medicaid Services notifies the facility or provider that 
93.20 	it may resume permitting the use of medical cannabis flower or medical cannabinoid products 
93.21 	within the facility or in the provider's service setting:
93.22 	(1) a federal regulatory agency or the United States Department of Justice initiates 
93.23 	enforcement action against a facility or provider related to the facility's compliance with 
93.24 	the medical cannabis program; or
93.25 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
93.26 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
93.27 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
93.28 	facilities or otherwise prohibits compliance with the medical cannabis program.
93.29 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
93.30 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
93.31 	of medical cannabis flower or medical cannabinoid products while carrying out employment 
93.32 	duties, including providing or supervising care to a patient enrolled in the registry program, 
93.33 	or distribution of medical cannabis flower or medical cannabinoid products to a patient 
93.34 	enrolled in the registry program who resides at or is actively receiving treatment or care at 
93.35 	the facility or from the provider with which the employee or agent is affiliated.

94.1 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.2 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.3 	is later.

94.4 	Sec. 101. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended 
94.5 	to read:
94.6 		Subdivision 1.Presumption. There is a presumption that a patient or other person 
94.7 	enrolled in the registry program is engaged in the authorized use or possession of medical
94.8 	cannabis flower and medical cannabinoid products. This presumption may be rebutted by 
94.9 	evidence that the patient's use of medical cannabis flower or medical cannabinoid products
94.10 	use or possession of cannabis flower or cannabinoid products by a patient or other person 
94.11 	enrolled in the registry program was not for the purpose of assisting with, treating, or 
94.12 	alleviating the patient's or other person's qualifying medical condition or symptoms associated 
94.13 	with the patient's or other person's qualifying medical condition.

94.14 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.15 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.16 	is later.

94.17 	Sec. 102. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended 
94.18 	to read:
94.19 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the use or 
94.20 	possession of cannabis flower, cannabinoid products, or cannabis paraphernalia by the 
94.21 	following are persons is not violations a violation of this chapter or chapter 152:
94.22 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
94.23 	medical cannabis paraphernalia by a patient or person enrolled in the registry program or 
94.24 	by a visiting patient to whom medical cannabis flower or medical cannabinoid products are 
94.25 	distributed under section 342.51, subdivision 5;
94.26 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
94.27 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
94.28 	spouse of a patient or person enrolled in the registry program; or
94.29 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
94.30 	cannabis paraphernalia by any person while that person is carrying out duties required under 
94.31 	sections 342.47 342.51 to 342.60.
95.1 	(b) The office of Cannabis Management, members of the Cannabis Advisory Council, 
95.2 	office of Cannabis Management employees, agents or contractors of the office of Cannabis 
95.3 	Management, and health care practitioners participating in the registry program are not 
95.4 	subject to any civil penalties or disciplinary action by the Board of Medical Practice, the 
95.5 	Board of Nursing, or any business, occupational, or professional licensing board or entity 
95.6 	solely for participating in the registry program either in a professional capacity or as a 
95.7 	patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or 
95.8 	disciplinary action by the Board of Pharmacy when acting in accordance with sections 
95.9 	342.47342.51 to 342.60 either in a professional capacity or as a patient. Nothing in this 
95.10 	section prohibits a professional licensing board from taking action in response to a violation 
95.11 	of law.
95.12 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
95.13 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
95.14 	any injury, loss of property, personal injury, or death caused by any act or omission while 
95.15 	acting within the scope of office or employment under sections 342.47 342.51 to 342.60.
95.16 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
95.17 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
95.18 	13.09, a violation of this paragraph is a gross misdemeanor.
95.19 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
95.20 	not release data or information about an individual contained in any report or document or 
95.21 	in the registry and must not release data or information obtained about a patient enrolled in 
95.22 	the registry program, except as provided in sections 342.47 342.51 to 342.60. 
95.23 	Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.
95.24 	(f) No information contained in a report or document, contained in the registry, or 
95.25 	obtained from a patient under sections 342.47 342.51 to 342.60 may be admitted as evidence 
95.26 	in a criminal proceeding, unless:
95.27 	(1) the information is independently obtained; or
95.28 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
95.29 	violation of sections 342.47 342.51 to 342.60.
95.30 	(g) Possession of a registry verification or an application for enrollment in the registry 
95.31 	program:
95.32 	(1) does not constitute probable cause or reasonable suspicion;
96.1 	(2) must not be used to support a search of the person or property of the person with a 
96.2 	registry verification or application to enroll in the registry program; and
96.3 	(3) must not subject the person or the property of the person to inspection by any 
96.4 	government agency.

96.5 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
96.6 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
96.7 	is later.

96.8 	Sec. 103. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 3, is amended 
96.9 	to read:
96.10 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll or 
96.11 	otherwise penalize a patient or person enrolled in the registry program as a pupil or otherwise 
96.12 	penalize a patient solely because the patient or person is enrolled in the registry program, 
96.13 	unless failing to do so would violate federal law or regulations or cause the school to lose 
96.14 	a monetary or licensing-related benefit under federal law or regulations.
96.15 	(b) No landlord may refuse to lease to a patient or person enrolled in the registry program 
96.16 	or otherwise penalize a patient or person enrolled in the registry program solely because 
96.17 	the patient or person is enrolled in the registry program, unless failing to do so would violate 
96.18 	federal law or regulations or cause the landlord to lose a monetary or licensing-related 
96.19 	benefit under federal law or regulations.

96.20 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
96.21 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
96.22 	is later.

96.23 	Sec. 104. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended 
96.24 	to read:
96.25 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
96.26 	patient's use of medical cannabis flower or medical cannabinoid products according to 
96.27 	sections 342.47 342.51 to 342.60 is considered the equivalent of the authorized use of a 
96.28 	medication used at the discretion of a health care practitioner and does not disqualify a 
96.29 	patient from needed medical care.

96.30 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
96.31 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
96.32 	is later.

97.1 	Sec. 105. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 5, is amended 
97.2 	to read:
97.3 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
97.4 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
97.5 	federal law or regulations, an employer may not discriminate against a person in hiring, 
97.6 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
97.7 	discrimination is based on:
97.8 	(1) the person's status as a patient or person enrolled in the registry program; or
97.9 	(2) a patient's positive drug test for cannabis components or metabolites, unless the 
97.10 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
97.11 	a medical cannabinoid product on work premises, during working hours, or while operating 
97.12 	an employer's machinery, vehicle, or equipment.
97.13 	(b) An employee who is a patient and whose employer requires the employee to undergo 
97.14 	drug testing according to section 181.953 may present the employee's registry verification 
97.15 	as part of the employee's explanation under section 181.953, subdivision 6.

97.16 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
97.17 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
97.18 	is later.

97.19 	Sec. 106. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 6, is amended 
97.20 	to read:
97.21 		Subd. 6.Custody; visitation; parenting time. A person must not be denied custody of 
97.22 	a minor child or visitation rights or parenting time with a minor child based solely on the 
97.23 	person's status as a patient or person enrolled in the registry program. There must be no 
97.24 	presumption of neglect or child endangerment for conduct allowed under sections 342.47
97.25 	342.51 to 342.60, unless the person's behavior creates an unreasonable danger to the safety 
97.26 	of the minor as established by clear and convincing evidence.

97.27 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
97.28 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
97.29 	is later.

98.1 	Sec. 107. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 7, is amended 
98.2 	to read:
98.3 		Subd. 7.Action for damages. In addition to any other remedy provided by law, a patient 
98.4 	or person enrolled in the registry program may bring an action for damages against any 
98.5 	person who violates subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is 
98.6 	liable to a patient or person enrolled in the registry program injured by the violation for the 
98.7 	greater of the person's actual damages or a civil penalty of $100 and reasonable attorney 
98.8 	fees.

98.9 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
98.10 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
98.11 	is later.

98.12 	Sec. 108. Minnesota Statutes 2023 Supplement, section 342.58, is amended to read:
98.13 	342.58 VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL 
98.14 	PENALTY.
98.15 	A health care practitioner who knowingly refers patients to a medical cannabis business 
98.16 	or to a designated caregiver, who advertises as a retailer or producer of medical cannabis 
98.17 	flower or medical cannabinoid products, or who issues certifications while holding a financial 
98.18 	interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and 
98.19 	may be sentenced to imprisonment for not more than 90 days or to payment of not more 
98.20 	than $1,000, or both.

98.21 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
98.22 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
98.23 	is later.

98.24 	Sec. 109. Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:
98.25 	342.60 APPLIED RESEARCH.
98.26 	The Division of Medical Cannabis office may conduct, or award grants to health care 
98.27 	providers or research organizations to conduct, applied research on the safety and efficacy 
98.28 	of using medical cannabis flower or medical cannabinoid products to treat a specific health 
98.29 	condition. A health care provider or research organization receiving a grant under this section 
98.30 	must provide the office with access to all data collected in applied research funded under 
98.31 	this section. The office may use data from applied research conducted or funded under this 
99.1 	section as evidence to approve additional qualifying medical conditions or additional 
99.2 	allowable forms of medical cannabis.

99.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
99.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
99.5 	is later.

99.6 	Sec. 110. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended 
99.7 	to read:
99.8 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
99.9 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
99.10 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
99.11 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
99.12 	medical cannabis combination business shall make each batch of cannabis flower, cannabis 
99.13 	products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived 
99.14 	consumer products grown, manufactured, or imported by the cannabis business or hemp 
99.15 	business available to a cannabis testing facility.
99.16 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
99.17 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
99.18 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
99.19 	medical cannabis combination business must disclose all known information regarding 
99.20 	pesticides, fertilizers, solvents, or other foreign materials, including but not limited to 
99.21 	catalysts used in creating artificially derived cannabinoids, applied or added to the batch of 
99.22 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
99.23 	edibles, or hemp-derived consumer products subject to testing. Disclosure must be made 
99.24 	to the cannabis testing facility and must include information about all applications by any 
99.25 	person, whether intentional or accidental.
99.26 	(c) The cannabis testing facility shall select one or more representative samples from 
99.27 	each batch, test the samples for the presence of contaminants, and test the samples for 
99.28 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
99.29 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
99.30 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
99.31 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
99.32 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
99.33 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
99.34 	cannabis business or hemp business any part of the sample that remains after testing.

100.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

100.2 	Sec. 111. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended 
100.3 	to read:
100.4 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
100.5 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
100.6 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
100.7 	endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis 
100.8 	cultivator, medical cannabis processor, or medical cannabis combination business and the 
100.9 	cannabis business or hemp business may then sell or transfer the batch of cannabis flower, 
100.10 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
100.11 	hemp-derived consumer products from which the sample was taken to another cannabis 
100.12 	business or hemp business, or offer the cannabis flower, cannabis products, lower-potency 
100.13 	hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a 
100.14 	sample does not meet the applicable testing standards or if the testing facility is unable to 
100.15 	test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which 
100.16 	the sample was taken shall be subject to procedures established by the office for such batches, 
100.17 	including destruction, remediation, or retesting.
100.18 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
100.19 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
100.20 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
100.21 	medical cannabis combination business must maintain the test results for cannabis flower, 
100.22 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
100.23 	hemp-derived consumer products grown, manufactured, or imported by that cannabis 
100.24 	business or hemp business for at least five years after the date of testing.
100.25 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
100.26 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
100.27 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
100.28 	medical cannabis combination business shall make test results maintained by that cannabis 
100.29 	business or hemp business available for review by any member of the public, upon request. 
100.30 	Test results made available to the public must be in plain language.

100.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

101.1 	Sec. 112. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended 
101.2 	to read:
101.3 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
101.4 	products that consist of hemp plant parts sold to customers or patients must have affixed 
101.5 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
101.6 	label that contains at least the following information:
101.7 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
101.8 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the 
101.9 	cannabis flower or hemp plant part was cultivated;
101.10 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
101.11 	container;
101.12 	(3) the batch number;
101.13 	(4) the cannabinoid profile;
101.14 	(5) a universal symbol established by the office indicating that the package or container 
101.15 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
101.16 	hemp-derived consumer product;
101.17 	(6) verification that the cannabis flower or hemp plant part was tested according to 
101.18 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
101.19 	standards;
101.20 	(7) the maximum dose, quantity, or consumption that may be considered medically safe 
101.21 	within a 24-hour period;
101.22 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
101.23 	(8) the following statement: "Keep this product out of reach of children."; and
101.24 	(9) any other statements or information required by the office.

101.25 	EFFECTIVE DATE. This section is effective the day following final enactment.

101.26 	Sec. 113. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended 
101.27 	to read:
101.28 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
101.29 	lower-potency hemp edibles, hemp-derived consumer products other than products subject 
101.30 	to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived 
102.1 	topical products sold to customers or patients must have affixed to the packaging or container 
102.2 	of the cannabis product a label that contains at least the following information:
102.3 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
102.4 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated 
102.5 	the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp 
102.6 	edible, hemp-derived consumer product, or medical cannabinoid product;
102.7 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
102.8 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
102.9 	processor, or industrial hemp grower that manufactured the cannabis concentrate, hemp 
102.10 	concentrate, or artificially derived cannabinoid and, if different, the name and license number 
102.11 	of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, or 
102.12 	lower-potency hemp edible manufacturer, or medical cannabis processor that manufactured 
102.13 	the product;
102.14 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
102.15 	hemp-derived consumer product in the package or container;
102.16 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
102.17 	product;
102.18 	(5) the batch number;
102.19 	(6) the serving size;
102.20 	(7) the cannabinoid profile per serving and in total;
102.21 	(8) a list of ingredients;
102.22 	(9) a universal symbol established by the office indicating that the package or container 
102.23 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
102.24 	hemp-derived consumer product;
102.25 	(10) a warning symbol developed by the office in consultation with the commissioner 
102.26 	of health and the Minnesota Poison Control System that:
102.27 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
102.28 	(ii) is in a highly visible color;
102.29 	(iii) includes a visual element that is commonly understood to mean a person should 
102.30 	stop;
102.31 	(iv) indicates that the product is not for children; and
103.1 	(v) includes the phone number of the Minnesota Poison Control System;
103.2 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
103.3 	consumer product, or medical cannabinoid product was tested according to section 342.61 
103.4 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
103.5 	or medical cannabinoid product complies with the applicable standards;
103.6 	(12) the maximum dose, quantity, or consumption that may be considered medically 
103.7 	safe within a 24-hour period;
103.8 	(12) information on the usage of the product;
103.9 	(13) the following statement: "Keep this product out of reach of children."; and
103.10 	(14) any other statements or information required by the office.
103.11 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
103.12 	hemp edibles that are imported into the state provided that those requirements provide 
103.13 	consumers with information that is substantially similar to the information described in 
103.14 	paragraph (a).

103.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

103.16 	Sec. 114. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 4, is amended 
103.17 	to read:
103.18 		Subd. 4.Additional content of label; medical cannabis flower and medical
103.19 	cannabinoid products. In addition to the applicable requirements for labeling under 
103.20 	subdivision 2 or 3, all medical cannabis flower sold to patients and medical cannabinoid 
103.21 	products sold to patients must include at least the following information on the label affixed 
103.22 	to the packaging or container of the medical cannabis flower or medical cannabinoid product:
103.23 	(1) the patient's name and date of birth;
103.24 	(2) the name and date of birth of the patient's registered designated caregiver or, if listed 
103.25 	on the registry verification, the name of the patient's parent, legal guardian, or spouse, if 
103.26 	applicable; and
103.27 	(3) the patient's registry identification number.

103.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

104.1 	Sec. 115. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended 
104.2 	to read:
104.3 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
104.4 	cannabis retailer, medical cannabis retailer, or medical cannabis combination business must 
104.5 	provide customers and patients with the following information:
104.6 	(1) factual information about impairment effects and the expected timing of impairment 
104.7 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
104.8 	lower-potency hemp edibles, and hemp-derived consumer products;
104.9 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
104.10 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
104.11 	hemp edibles, and hemp-derived consumer products;
104.12 	(3) resources customers and patients may consult to answer questions about cannabis 
104.13 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
104.14 	products, and any side effects and adverse effects;
104.15 	(4) contact information for the poison control center and a safety hotline or website for 
104.16 	customers to report and obtain advice about side effects and adverse effects of cannabis 
104.17 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
104.18 	products;
104.19 	(5) substance use disorder treatment options; and
104.20 	(6) any other information specified by the office.
104.21 	(b) A cannabis microbusiness, cannabis mezzobusiness, or cannabis retailer, or medical 
104.22 	cannabis retailer may include the information described in paragraph (a) on the label affixed 
104.23 	to the packaging or container of cannabis flower, cannabis products, lower-potency hemp 
104.24 	edibles, and hemp-derived consumer products by:
104.25 	(1) posting the information in the premises of the cannabis microbusiness, cannabis 
104.26 	mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination 
104.27 	business; or
104.28 	(2) providing the information on a separate document or pamphlet provided to customers 
104.29 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
104.30 	hemp edible, or a hemp-derived consumer product.

104.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

105.1 	Sec. 116. Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to 
105.2 	read:

105.3 	EFFECTIVE DATE. This section is effective July 1, 2023, except for subdivision 3, 
105.4 	which is effective March 1, 2025.

105.5 	Sec. 117. Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to 
105.6 	read:

105.7 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
105.8 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
105.9 	is later.

105.10 	Sec. 118. Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to 
105.11 	read:

105.12 	EFFECTIVE DATE. This section is effective March 1, 2025 the day following final 
105.13 	enactment.

105.14 	Sec. 119. Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to 
105.15 	read:

105.16 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
105.17 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
105.18 	is later.

105.19 	Sec. 120. Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to 
105.20 	read:

105.21 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
105.22 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
105.23 	is later.

105.24 	Sec. 121. Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to 
105.25 	read:

105.26 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
105.27 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
105.28 	is later.

106.1 	Sec. 122. Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to 
106.2 	read:

106.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
106.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
106.5 	is later.

106.6 	Sec. 123. Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to 
106.7 	read:

106.8 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
106.9 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
106.10 	is later.

106.11 	Sec. 124. Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to 
106.12 	read:

106.13 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
106.14 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
106.15 	is later.

106.16 	Sec. 125. Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to 
106.17 	read:

106.18 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
106.19 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
106.20 	is later.

106.21 	Sec. 126. Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to 
106.22 	read:

106.23 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
106.24 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
106.25 	is later.

106.26 	Sec. 127. Laws 2023, chapter 63, article 6, section 10, the effective date, is amended to 
106.27 	read:

106.28 	EFFECTIVE DATE. This section is effective March July 1, 2025 2024.

107.1 	Sec. 128. Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to 
107.2 	read:

107.3 	EFFECTIVE DATE. Paragraph (a) is effective MarchDecember 1, 2025. Paragraph 
107.4 	(b) is effective August 1, 2023. Paragraph (c) is effective July 1, 2023.

107.5 	Sec. 129. EMPLOYEE TRANSFER.
 107.6 	(a) The powers, duties, rights, obligations, and other authority imposed by law on the 
107.7 	Department of Health with respect to the sale of certain cannabinoid products under 
107.8 	Minnesota Statutes, section 151.72, are transferred to the Office of Cannabis Management 
107.9 	under Minnesota Statutes, section 15.039.
107.10 	(b) The following protections shall apply to employees who are transferred from the 
107.11 	Department of Health to the Office of Cannabis Management:
107.12 	(1) the employment status and job classification of a transferred employee shall not be 
107.13 	altered as a result of the transfer;
107.14 	(2) transferred employees who were represented by an exclusive representative prior to 
107.15 	the transfer shall continue to be represented by the same exclusive representative after the 
107.16 	transfer;
107.17 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
107.18 	continue in full force and effect for such transferred employees after the transfer;
107.19 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
107.20 	employees about any proposed changes affecting or relating to the transferred employees' 
107.21 	terms and conditions of employment to the extent such changes are not addressed in the 
107.22 	applicable collective bargaining agreement; and
107.23 	(5) for an employee in a temporary unclassified position transferred to the Office of 
107.24 	Cannabis Management, the total length of time that the employee has served in the 
107.25 	appointment shall include all time served in the appointment at the transferring agency and 
107.26 	the time served in the appointment at the Office of Cannabis Management. An employee 
107.27 	in a temporary unclassified position who was hired by a transferring agency through an 
107.28 	open competitive selection process in accordance with a policy enacted by Minnesota 
107.29 	Management and Budget shall be considered to have been hired through such process after 
107.30 	the transfer.

108.1 	Sec. 130. TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
 108.2 	The Department of Health shall transfer all data, including not public data as defined in 
108.3 	Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
108.4 	complaints involving alleged violations of Minnesota Statutes 2022, section 151.72, as well 
108.5 	as registration data collected under Minnesota Statutes 2022, section 151.72, subdivision 
108.6 	5b, to the Office of Cannabis Management. The Department of Health and the Office of 
108.7 	Cannabis Management shall ensure that the transfer takes place in a manner and on a schedule 
108.8 	that prioritizes public health.

108.9 	Sec. 131. TRANSFER OF MEDICAL PROGRAM.
 108.10 	(a) Notwithstanding the data's classification under Minnesota Statutes, chapter 13, the 
108.11 	Office of Cannabis Management may access data maintained by the commissioner of health 
108.12 	related to the responsibilities transferred under Minnesota Statutes, section 342.02, 
108.13 	subdivision 3. Data sharing authorized by this subdivision includes nonpublic data as defined 
108.14 	in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
108.15 	complaints involving any alleged violation of Minnesota Statutes, sections 152.22 to 152.37, 
108.16 	by a medical cannabis manufacturer. Data sharing under this paragraph further includes 
108.17 	data in patient files maintained by the commissioner and the health care practitioner and 
108.18 	data submitted to or by a medical cannabis manufacturer classified as private data on 
108.19 	individuals, as defined in Minnesota Statutes, section 13.02, subdivision 12, or nonpublic 
108.20 	data, as defined in Minnesota Statutes, section 13.02, subdivision 9. Any data shared under 
108.21 	this section retain the data's classification from the agency holding the data.
108.22 	(b) All rules adopted by the commissioner of health pursuant to Minnesota Statutes, 
108.23 	sections 152.22 to 152.37, including but not limited to Minnesota Rules, chapter 4770, 
108.24 	remain effective and shall be enforced until amended or repealed consistent with Minnesota 
108.25 	Statutes, section 15.039, subdivision 3.
108.26 	(c) The director of the Office of Cannabis Management may use the good cause exempt 
108.27 	rulemaking process under Minnesota Statutes, section 14.388, subdivision 1, clauses (3) 
108.28 	and (4), to copy and adopt any portions of Minnesota Rules, parts 4770.0100 to 4770.4030, 
108.29 	that are necessary to effectuate the transfer of authority granted under Minnesota Statutes, 
108.30 	section 342.02, subdivision 3. The commissioner may make technical changes and any 
108.31 	changes necessary to conform with the transfer of authority. Any change to the rules that 
108.32 	is not authorized under this paragraph must be adopted according to Minnesota Statutes, 
108.33 	sections 14.001 to 14.366.
109.1 	(d) Unless otherwise specified in this section or Minnesota Statutes, section 342.02, 
109.2 	subdivision 3, transfer of the powers, duties, rights, obligations, and other authority imposed 
109.3 	by law on the Department of Health with respect to the medical cannabis program under 
109.4 	Minnesota Statutes 2022, sections 152.22 to 152.37, to the Office of Cannabis Management 
109.5 	is subject to Minnesota Statutes, section 15.039.

109.6 	Sec. 132. REPEALER.
 109.7 	(a) Minnesota Statutes 2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54, 
109.8 	and 55; 342.18, subdivision 1; 342.27, subdivision 13; and 342.29, subdivision 9, are 
109.9 	repealed.
109.10 	(b) Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; 342.50; and 
109.11 	342.52, subdivision 8, are repealed.
109.12 	(c) Laws 2023, chapter 63, article 7, sections 4; and 6, are repealed.
109.13 	(d) Minnesota Statutes 2022, sections 152.22, subdivision 3; and 152.36, are repealed.

109.14 	EFFECTIVE DATE. Paragraphs (a) and (c) are effective the day following final 
109.15 	enactment. Paragraph (b) is effective March 1, 2025, or upon the adoption of initial rules 
109.16 	pertaining to medical cannabis under section 342.02, subdivision 5, whichever is later. 
109.17 	Paragraph (d) is effective July 1, 2024.

APPENDIX 

Repealed Minnesota Statutes: S4782-4 

152.22 DEFINITIONS.Subd. 3.Disqualifying felony offense. 
"Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis. 

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH.Subdivision 1.Task force on medical cannabis therapeutic research. 
(a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members: 

(1) two members of the house of representatives, one selected by the speaker of the house, the other selected by the minority leader; 

(2) two members of the senate, one selected by the majority leader, the other selected by the minority leader; 

(3) four members representing consumers or patients enrolled in the registry program, including at least two parents of patients under age 18; 

(4) four members representing health care providers, including one licensed pharmacist; 

(5) four members representing law enforcement, one from the Minnesota Chiefs of Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and Peace Officers Association, and one from the Minnesota County Attorneys Association; 

(6) four members representing substance use disorder treatment providers; and 

(7) the commissioners of health, human services, and public safety. 

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed by the governor under the appointment process in section 15.0597. Members shall serve on the task force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014, and the commissioner of health shall convene the first meeting of the task force by August 1, 2014. 

(c) There shall be two cochairs of the task force chosen from the members listed under paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected by the majority leader of the senate. The authority to convene meetings shall alternate between the cochairs. 

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall receive expenses as provided in section 15.059, subdivision 6. 

Subd. 1a.Administration. 
The commissioner of health shall provide administrative and technical support to the task force. 

Subd. 2.Impact assessment. 
The task force shall hold hearings to evaluate the impact of the use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp, including, but not limited to: 

(1) program design and implementation; 

(2) the impact on the health care provider community; 

(3) patient experiences; 

(4) the impact on the incidence of substance abuse; 

(5) access to and quality of medical cannabis, hemp, and medical cannabis products; 

(6) the impact on law enforcement and prosecutions; 

(7) public awareness and perception; and 

(8) any unintended consequences. 

Subd. 3.Cost assessment. 
By January 15 of each year, beginning January 15, 2015, and ending January 15, 2019, the commissioners of state departments impacted by the medical cannabis therapeutic research study shall report to the cochairs of the task force on the costs incurred by each department on implementing sections 152.22 to 152.37. The reports must compare actual costs to the estimated costs of implementing these sections and must be submitted to the task force on medical cannabis therapeutic research. 

Subd. 4.Reports to the legislature. 
(a) The cochairs of the task force shall submit the following reports to the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health and human services, public safety, judiciary, and civil law: 

(1) by February 1, 2015, a report on the design and implementation of the registry program; and every two years thereafter, a complete impact assessment report; and 

(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed cost assessment. 

(b) The task force may make recommendations to the legislature on whether to add or remove conditions from the list of qualifying medical conditions. 

Subd. 5.No expiration. 
The task force on medical cannabis therapeutic research does not expire. 

342.01 DEFINITIONS.Subd. 28.Division of Medical Cannabis. 
"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program. 

Subd. 52.Medical cannabinoid product. 
(a) "Medical cannabinoid product" means a product that: 

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with cannabinoids, including but not limited to artificially derived cannabinoids; and 

(2) is provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical condition. 

(b) A medical cannabinoid product must be in the form of: 

(1) liquid, including but not limited to oil; 

(2) pill; 

(3) liquid or oil for use with a vaporized delivery method; 

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles; 

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and sublingual tablets; 

(6) edible products in the form of gummies and chews; 

(7) topical formulation; or 

(8) any allowable form or delivery method approved by the office. 

(c) Medical cannabinoid product does not include adult-use cannabis products or hemp-derived consumer products. 

Subd. 53.Medical cannabis business. 
"Medical cannabis business" means an entity licensed under this chapter to engage in one or more of the following: 

(1) the cultivation of cannabis plants for medical cannabis flower; 

(2) the manufacture of medical cannabinoid products; and 

(3) the retail sale of medical cannabis flower and medical cannabinoid products. 

Subd. 54.Medical cannabis flower. 
"Medical cannabis flower" means cannabis flower provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical cannabis business to treat or alleviate the symptoms of a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis flower. 

Subd. 55.Medical cannabis paraphernalia. 
"Medical cannabis paraphernalia" means a delivery device, related supply, or educational material used by a patient enrolled in the registry program to administer medical cannabis and medical cannabinoid products. 

342.18 LICENSE SELECTION CRITERIA.Subdivision 1.Market stability. 
The office shall issue the necessary number of licenses in order to ensure the sufficient supply of cannabis flower and cannabis products to meet demand, provide market stability, ensure a competitive market, and limit the sale of unregulated cannabis flower and cannabis products. 

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.Subd. 13.Adult-use and medical cannabis; colocation. 
(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises. 

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient. 

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.Subd. 9.Medical cannabis endorsement. 
A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office. 

342.47 MEDICAL CANNABIS BUSINESS LICENSES.Subdivision 1.License types. 
(a) The office shall issue the following types of medical cannabis business licenses: 

(1) medical cannabis cultivator; 

(2) medical cannabis processor; 

(3) medical cannabis retailer; and 

(4) medical cannabis combination business license. 

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses. 

Subd. 2.Multiple licenses; limits. 
(a) Except as provided in subdivision 3, a person, cooperative, or business holding: 

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; 

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or 

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses. 

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business. 

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold. 

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business. 

Subd. 3.Medical cannabis combination business license. 
(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business. 

(b) A person or business may only hold one medical cannabis combination license. 

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.
In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office: 

(1) for medical cannabis cultivator license applicants: 

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and 

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought; 

(2) for medical cannabis processor license applicants: 

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration; 

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and 

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought; 

(3) for medical cannabis retailer license applicants: 

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business; 

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and 

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or 

(4) for medical cannabis combination license applicants: 

(i) the information required under clauses (1) to (3); and 

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3. 

342.49 MEDICAL CANNABIS CULTIVATORS.
(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office. 

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25. 

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity. 

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023. 

342.50 MEDICAL CANNABIS PROCESSORS.
(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and 

(7) perform other actions approved by the office. 

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements. 

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity. 

342.52 PATIENT REGISTRY PROGRAM.Subd. 8.Allowable delivery methods. 
A patient in the registry program may receive medical cannabis flower and medical cannabinoid products. The office may approve additional delivery methods to expand the types of products that qualify as medical cannabinoid products. 

Repealed Minnesota Session Laws: S4782-4 

Laws 2023, chapter 63, article 7, section 4
Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT. 
(a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. 

(b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. 

(c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. 

(d) This section shall expire on March 1, 2025. 

EFFECTIVE DATE. 
This section is effective the day following final enactment. 

Laws 2023, chapter 63, article 7, section 6
Sec. 6. REPEALER. Minnesota Statutes 2022, section 151.72, is repealed.
EFFECTIVE DATE. 
This section is effective March 1, 2025.